Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3019420	s-trypt	ug/l (ug/l)	2149	3241	0.06%
3019420	s-trypt	— (—)	290	324	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other and unspecified urticaria

517

363

15.01

307.65

1.3

1.5

5.69

7.75

ug/l

2.32

461

321

Adverse effects, not elsewhere classified

736

357

22.27

307.65

1.5

7.78

7.30

ug/l

0.20

631

325

Urticaria and erythema

728

675

11.17

307.65

1.4

1.5

6.26

8.02

ug/l

1.17

659

607

Other and unspecified effects of external causes

766

507

15.92

307.65

1.5

1.6

7.68

7.32

ug/l

0.17

660

467

Urticaria

687

571

12.55

307.65

1.3

1.5

5.71

7.68

ug/l

2.58

622

512

Dermatitis and eczema

889

1401

3.97

260.54

1.4

1.6

6.81

8.71

ug/l

2.12

812

1259

Diseases of the skin and subcutaneous tissue

677

634

5.40

253.68

1.4

1.7

6.43

9.96

ug/l

3.07

612

565

Allergic rhinitis

377

532

7.14

248.68

1.3

1.6

6.41

7.23

ug/l

0.46

344

490

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

207

160

13.61

218.06

1.8

1.5

11.11

8.57

ug/l

0.50

184

136

Pollen allergy

310

429

7.34

208.27

1.3

1.5

5.25

6.47

ug/l

1.50

280

381

ILD medications: prednisolone, methylprednisolone, prednisone

813

1248

3.67

207.03

1.5

7.65

8.24

ug/l

0.28

725

1140

Oral corticosteroids

793

1330

3.57

198.29

1.4

1.5

7.47

8.04

ug/l

0.28

707

1208

Vasomotor and allergic rhinitis

406

765

5.29

197.75

1.3

1.5

6.70

7.52

ug/l

0.40

368

696

ILD medications

805

1283

3.43

184.00

1.5

7.81

8.16

ug/l

0.15

719

1171

Actinic keratosis

281

380

6.94

176.44

1.2

1.8

7.27

10.50

ug/l

1.79

272

338

Skin changes due to chronic exposure to nonionizing radiation

283

397

6.66

170.88

1.2

1.8

7.26

10.39

ug/l

1.80

274

353

293

429

6.34

168.47

1.4

1.8

8.23

10.30

ug/l

0.69

284

382

Dermatitis

456

1101

4.17

167.52

1.5

7.67

9.00

ug/l

0.77

420

995

Asthma (only as main-diagnosis)

551

779

4.13

165.55

1.4

1.6

7.06

8.43

ug/l

0.83

493

724

Asthma (only as main-diagnosis), excluding more controls

546

755

4.17

165.23

1.3

1.6

6.70

8.44

ug/l

1.27

488

702

Inflammatory bowel disease treatment related agents

794

1404

3.19

164.73

1.4

1.5

7.81

8.11

ug/l

0.13

711

1278

Other and unspecified dermatitis

404

906

4.51

164.44

1.5

1.6

7.80

9.26

ug/l

0.72

375

819

Asthma and allergy

174

156

11.25

163.56

1.4

6.98

6.59

ug/l

0.10

159

143

Other and unspecified drugs and medicaments

169

151

11.70

162.43

1.7

1.5

10.03

9.29

ug/l

0.13

147

130

First line medication for Crohn's disease

757

1262

3.26

161.05

1.5

7.75

8.31

ug/l

0.25

678

1150

Examination and observation for other reasons

408

451

5.28

160.76

1.4

1.6

7.95

7.25

ug/l

0.25

381

398

Asthma (mode)

565

782

3.90

153.19

1.4

1.6

6.15

8.42

ug/l

2.50

508

727

Melanocytic naevi, other sites/unspecified

166

159

10.93

152.28

1.2

1.6

6.46

7.99

ug/l

0.55

160

137

Symptoms and signs involving the skin and subcutaneous tissue

534

1514

3.48

150.97

1.4

1.5

8.57

7.87

ug/l

0.24

495

1362

Asthma

550

779

3.73

139.63

1.4

1.6

6.09

8.43

ug/l

2.61

493

724

Oedema, not elsewhere classified

266

477

5.57

137.91

1.6

1.5

7.15

8.70

ug/l

0.84

236

433

Asthma, excluding more controls

538

755

3.74

137.02

1.4

1.6

6.11

8.44

ug/l

2.49

481

702

Asthma and allergy, excluding more controls

174

203

8.64

134.97

1.4

6.98

6.35

ug/l

0.17

159

179

Dermatographic urticaria

131

106

12.91

134.11

1.4

1.6

5.47

8.01

ug/l

0.89

119

Asthma, hospital admissions , main diagnosis only

584

1701

3.05

129.89

1.5

7.65

8.15

ug/l

0.22

524

1545

Atopic dermatitis

459

1056

3.60

129.60

1.3

1.5

5.41

8.11

ug/l

4.13

422

940

Allergic urticaria

136

123

11.45

129.47

1.4

1.5

5.16

7.11

ug/l

0.99

128

105

Other special examinations and investigations of persons without complaint or reported diagnosis

404

451

4.57

128.89

1.4

1.6

6.93

7.25

ug/l

0.18

368

398

Asthma (diagnoses ohter than nonallergic)

597

1704

2.93

121.62

1.5

7.71

8.06

ug/l

0.15

538

1545

Allergic asthma (mode)

220

380

5.74

117.48

1.4

1.5

6.84

8.19

ug/l

0.38

198

348

Allergic asthma (mode), excluding more controls

220

381

5.73

117.13

1.4

1.5

6.84

8.16

ug/l

0.37

198

350

Melanocytic naevi

284

635

4.54

116.43

1.3

1.5

7.05

7.73

ug/l

0.27

268

567

348

907

3.85

114.44

1.5

8.02

7.53

ug/l

0.14

319

813

Medical observation and evaluation for suspected diseases and conditions

370

451

4.22

108.70

1.6

7.69

7.25

ug/l

0.20

344

398

Desensitization to allergens

130

143

9.55

108.01

1.4

1.5

5.50

7.37

ug/l

0.81

119

122

Asthma, hospital admission 2, infections

400

1184

3.33

105.98

1.6

1.5

8.33

8.37

ug/l

0.01

367

1071

Asthma-related infections

400

1184

3.33

105.98

1.6

1.5

8.33

8.37

ug/l

0.01

367

1071

Other skin changes

173

274

6.43

104.15

1.2

1.6

8.02

9.42

ug/l

0.34

165

244

Seborrhoeic keratosis

182

313

5.90

100.77

1.3

1.7

8.14

9.82

ug/l

0.51

174

273

Atopic dermatitis, strict definition with reimbursement

268

617

4.25

100.04

1.3

1.5

5.42

7.89

ug/l

2.42

241

545

Other disorders of skin and subcutaneous tissue

430

1239

3.11

99.00

1.4

1.5

9.15

8.32

ug/l

0.28

401

1114

Headache

435

1118

3.13

98.60

1.5

7.49

7.85

ug/l

0.12

400

1013

Asthma, including avohilmo

709

1593

2.51

97.36

1.4

1.5

7.18

8.21

ug/l

0.67

638

1446

Toxic effect of contact with venomous animals

13.06

96.46

1.5

1.6

5.48

7.20

ug/l

0.54

Dermatitis due to ingested food

16.73

95.52

1.6

1.2

8.06

5.18

ug/l

0.50

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

13.80

92.94

1.4

1.5

6.07

7.59

ug/l

0.37

Other disorders of white blood cells

11.36

92.50

1.4

1.7

8.91

8.82

ug/l

0.01

Unspecified privation

141

208

6.96

91.09

1.5

6.62

8.78

ug/l

1.06

131

181

Complications of medical and surgical care

460

1510

2.82

90.06

1.7

1.5

10.02

7.95

ug/l

0.85

414

1373

Pain in joint

374

730

3.29

85.79

1.5

1.6

7.85

7.57

ug/l

0.09

344

660

Chronic lower respiratory diseases

700

1575

2.38

84.51

1.4

1.5

7.85

7.83

ug/l

0.01

629

1430

Allergic contact dermatitis

144

235

6.25

84.28

1.2

1.6

5.13

8.74

ug/l

2.96

132

205

General symptoms and signs

611

1202

2.56

84.05

1.5

7.73

7.77

ug/l

0.02

547

1090

Exposure to unspecified factor

599

1770

2.45

83.63

1.4

1.5

8.50

7.79

ug/l

0.28

501

1645

Asthma/COPD (KELA code 203)

558

1572

2.45

76.91

1.5

7.33

7.83

ug/l

0.25

505

1428

Asthma, unspecified (mode), excluding more controls

304

686

3.34

75.18

1.5

1.6

7.08

8.55

ug/l

0.89

276

639

Asthma, unspecified (mode)

305

707

3.27

73.22

1.5

1.6

7.07

8.55

ug/l

0.92

277

658

Other complications of surgical and medical care, not elsewhere classified

117

191

6.27

68.60

2.0

1.5

15.09

8.05

ug/l

1.11

105

163

Fever of other and unknown origin

319

962

2.97

68.34

1.4

1.5

7.28

8.13

ug/l

0.48

289

876

General examination and investigation of persons without complaint and reported diagnosis

289

451

3.36

63.95

1.4

1.6

8.88

7.25

ug/l

0.54

270

398

Other diseases of upper respiratory tract

552

1239

2.33

63.71

1.5

8.34

8.12

ug/l

0.08

489

1133

Atopic dermatitis, strict definition

253

778

3.22

63.43

1.3

1.5

5.40

6.95

ug/l

1.90

228

699

Other soft tissue disorders, not elsewhere classified

517

1309

2.33

61.41

1.5

1.6

8.82

8.07

ug/l

0.26

466

1180

Abnormalities of breathing

495

1223

2.36

60.71

1.4

1.5

6.97

7.97

ug/l

0.48

438

1117

Persons encountering health services for examination and investigation

287

451

3.20

58.39

1.5

1.6

7.87

7.25

ug/l

0.29

253

398

Toxic effects of substances chiefly nonmedicinal as to source

118

227

5.30

58.16

1.5

5.81

8.06

ug/l

1.32

103

202

Obesity related asthma

215

649

3.34

57.78

1.4

1.6

7.74

8.38

ug/l

0.20

200

583

Malignant neoplasm of skin

259

568

3.15

56.96

1.2

1.5

6.41

9.17

ug/l

2.04

247

494

Pain in throat and chest

454

1161

2.36

56.11

1.5

7.61

7.75

ug/l

0.06

405

1061

Disturbances of skin sensation

197

578

3.44

55.44

1.5

1.6

7.72

7.77

ug/l

0.01

181

514

Other specific joint derangements/joint disorders

428

1167

2.38

55.11

1.5

7.68

7.58

ug/l

0.03

391

1051

Liquid cancers, helper endpoint

196

490

3.51

55.01

3.7

1.4

20.67

8.11

ug/l

4.70

187

424

Other pulmonary diagnosis

397

787

2.54

54.07

1.5

1.6

7.95

8.39

ug/l

0.16

347

732

Excluding asthma or asthma-COPD overlap

396

787

2.53

53.68

1.5

1.6

7.91

8.39

ug/l

0.18

348

732

Migraine

338

1081

2.55

53.23

1.4

6.57

7.26

ug/l

0.26

313

971

COPD differential diagnosis

392

782

2.52

52.75

1.5

1.6

7.94

8.42

ug/l

0.18

345

727

ILD differential diagnosis

392

782

2.52

52.75

1.5

1.6

7.94

8.42

ug/l

0.18

345

727

Acute upper respiratory infections

535

1556

2.13

52.27

1.4

1.5

7.64

8.20

ug/l

0.25

490

1407

ILD medications: immunosuppressive drugs

316

1151

2.56

51.89

1.4

1.5

8.17

ug/l

0.00

286

1047

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

269

954

2.75

51.45

1.4

1.5

6.68

8.23

ug/l

1.14

225

875

Tramadol

417

1104

2.33

50.61

1.6

1.5

9.40

7.73

ug/l

0.66

383

990

Dorsalgia

517

1290

2.16

50.33

1.5

8.29

7.51

ug/l

0.29

469

1162

Malaise and fatigue

255

720

2.87

50.21

1.7

1.5

10.36

8.69

ug/l

0.34

230

660

Basal cell carcinoma

216

467

3.22

49.59

1.2

1.5

6.48

9.56

ug/l

1.87

204

405

Symptoms and signs involving the circulatory and respiratory systems

522

1228

2.14

48.90

1.5

6.86

7.97

ug/l

0.75

464

1122

Chronic rhinitis, nasopharyngitis and pharyngitis

190

591

3.24

48.70

1.4

6.77

7.81

ug/l

0.50

173

540

Basal cell carcinoma, including avohilmo

222

492

3.13

48.58

1.2

1.5

6.53

9.31

ug/l

1.73

209

430

Chronic sinusitis

231

807

2.88

48.28

1.5

1.6

8.51

8.47

ug/l

0.01

201

735

Cough

225

730

2.93

48.10

1.5

9.11

8.36

ug/l

0.13

203

666

Low back pain

393

1238

2.29

47.69

1.5

8.08

7.52

ug/l

0.29

354

1116

Undetermined asthma, excluding more controls

167

5.51

47.17

1.5

9.05

7.52

ug/l

0.37

152

Other headache syndromes

257

967

2.67

46.64

1.7

1.5

7.87

8.13

ug/l

0.09

237

877

Diseases of oesophagus, stomach and duodenum

536

1579

2.04

46.64

1.4

1.5

7.36

7.84

ug/l

0.31

492

1423

Pain, not elsewhere classified

166

488

3.43

46.61

1.5

1.4

9.00

7.64

ug/l

0.34

155

444

Exposure to other specified factors

414

1762

2.17

46.37

1.4

1.5

6.93

8.14

ug/l

0.86

363

1607

Undetermined asthma

171

5.38

45.97

1.5

9.05

7.48

ug/l

0.38

155

Other diseases of blood and blood-forming organs, wide

149

415

3.63

45.52

1.9

1.5

10.92

8.12

ug/l

0.88

133

372

Localized swelling, mass and lump of skin and subcutaneous tissue

178

557

3.22

45.23

1.3

1.5

11.40

8.05

ug/l

0.51

168

501

Lower back pain or/and sciatica

534

1751

2.00

45.09

1.5

8.43

7.89

ug/l

0.22

485

1585

Melanocytic naevi of trunk

105

230

4.64

44.50

1.2

1.5

5.75

8.62

ug/l

1.89

100

198

Acute upper respiratory infections of multiple and unspecified sites

395

1340

2.19

43.73

1.5

1.6

8.01

8.23

ug/l

0.06

359

1208

Abnormalities of heart beat

192

628

3.02

43.52

1.5

7.31

8.48

ug/l

0.41

175

576

Other intervertebral disc disorders

407

1114

2.21

43.51

1.5

8.78

7.59

ug/l

0.47

379

1003

Sciatica+with lumbago

268

978

2.53

43.03

1.5

8.69

7.68

ug/l

0.26

244

880

Other dorsopathies, not elsewhere classified

505

1296

2.05

42.99

1.5

7.67

7.50

ug/l

0.06

467

1166

Pain in limb

406

1258

2.17

42.63

1.4

1.6

8.84

7.86

ug/l

0.33

367

1134

Complications of surgical and medical care, not elsewhere classified

489

1670

2.01

42.58

1.7

1.5

10.14

7.66

ug/l

1.20

440

1516

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

328

1407

2.28

42.03

1.3

1.5

6.04

7.79

ug/l

2.30

304

1258

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

222

528

2.87

41.86

1.2

1.5

7.03

9.38

ug/l

1.28

210

462

Follow-up examination after treatment for conditions other than malignant neoplasms

184

382

3.20

41.45

1.6

1.5

7.10

ug/l

0.00

167

339

Other malignant neoplasms of skin (=non-melanoma skin cancer)

209

491

2.93

41.18

1.2

1.5

6.59

9.37

ug/l

1.70

198

427

Disorders of conjunctiva

445

1768

2.03

40.97

1.3

1.6

6.13

8.53

ug/l

3.79

413

1592

Supplementary factors related to causes of morbidity and mortality classified elsewhere

198

698

2.86

40.92

1.4

1.5

7.30

7.77

ug/l

0.24

180

625

548

1460

1.95

40.55

1.4

1.5

7.78

7.89

ug/l

0.04

500

1320

Disorders of skin appendages

283

1198

2.37

40.10

1.2

1.5

5.83

7.44

ug/l

2.38

259

1078

Conjunctivitis

419

1713

2.05

40.09

1.3

1.6

6.01

8.36

ug/l

3.86

389

1542

Asthma, hospital admissions 3, pneumonia

175

581

3.02

40.08

1.7

1.6

10.79

8.53

ug/l

0.42

157

519

Asthma-related pneumonia or sepsis

175

581

3.02

40.08

1.7

1.6

10.79

8.53

ug/l

0.42

157

519

Acute generalized exanthematous pustulosis

7.46

39.98

1.6

1.4

7.23

5.82

ug/l

0.81

Asthma-related pneumonia

174

578

3.02

39.82

1.7

1.6

10.79

8.54

ug/l

0.42

157

517

Neurotic, stress-related and somatoform disorders

470

1663

1.98

39.61

1.4

1.5

6.27

8.27

ug/l

2.94

428

1497

Allergic conjunctivitis

335

1490

2.20

39.60

1.3

1.5

6.10

7.70

ug/l

2.08

310

1335

Anxiety disorders

472

1667

1.98

39.51

1.4

1.5

6.26

8.27

ug/l

2.99

430

1501

Bronchitis

530

1750

1.91

39.30

1.4

1.5

7.76

7.87

ug/l

0.04

482

1583

Benign neoplasms

481

1334

1.99

38.83

1.4

1.6

8.27

7.87

ug/l

0.13

439

1196

Migraine with aura

179

619

2.92

38.37

1.5

1.4

7.42

6.58

ug/l

0.18

171

547

Chronic diseases of tonsils and adenoids

381

1130

2.14

38.27

1.5

1.6

7.77

7.96

ug/l

0.06

348

1033

Gastro-oesophageal reflux disease

333

1316

2.19

38.12

1.4

1.5

6.91

8.23

ug/l

0.95

308

1191

Congenital malformations, deformations and chromosomal abnormalities

364

1604

2.10

37.82

3.1

1.2

16.13

6.21

ug/l

6.10

338

1437

Immunodeficiencies

6.51

37.70

2.2

1.6

12.55

7.03

ug/l

0.49

Dyspnoea

430

1593

2.00

37.60

1.4

1.5

7.56

8.15

ug/l

0.22

386

1452

Type of accident

181

637

2.86

37.58

1.4

1.5

7.44

7.51

ug/l

0.03

165

566

Functional dyspepsia

160

527

3.06

37.40

1.6

1.5

10.65

7.80

ug/l

0.82

142

467

Anxiety disorders, excluding more controls

432

1405

2.01

37.05

1.4

1.5

6.37

8.40

ug/l

2.60

396

1267

Other diseases of intestines

533

1617

1.88

36.69

1.4

1.5

7.60

8.04

ug/l

0.17

480

1461

Implicit viral Sepsis

119

332

3.62

36.34

1.5

9.24

7.69

ug/l

0.31

111

296

Implicit viral Sepsis

156

515

3.05

36.29

1.6

1.5

8.98

7.90

ug/l

0.25

146

463

Pruritus

162

4.94

36.28

1.3

1.6

6.80

9.11

ug/l

0.88

139

Any gastric operation

393

939

2.11

35.74

1.6

1.3

7.38

6.94

ug/l

0.22

350

849

GASTRO-related operations

393

939

2.11

35.74

1.6

1.3

7.38

6.94

ug/l

0.22

350

849

Viral Sepsis

119

337

3.56

35.55

1.5

9.24

7.64

ug/l

0.33

111

300

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

466

1684

1.91

35.41

1.7

1.5

10.06

7.53

ug/l

1.48

419

1534

Diarrhoea and gastroenteritis of presumed infectious origin

489

1714

1.89

35.21

1.4

1.5

7.04

8.11

ug/l

0.85

447

1546

Suggestive for eosinophilic asthma

140

5.22

35.17

1.4

1.6

8.51

9.93

ug/l

0.25

123

Congenital malformations, deformations and chromosomal abnormalities

336

1534

2.10

34.96

3.2

1.2

16.63

5.93

ug/l

6.31

312

1379

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

7.10

34.92

2.6

1.5

13.24

7.46

ug/l

0.41

All anxiety disorders

354

1350

2.08

34.91

1.4

1.5

6.23

7.70

ug/l

1.65

320

1211

Myalgia

145

470

3.11

34.88

1.4

1.5

9.20

7.54

ug/l

0.25

134

421

Diseases of the respiratory system

288

609

2.38

34.66

1.5

7.53

8.56

ug/l

0.42

250

566

Other/unspecified dorsalgia

190

710

2.67

34.53

1.7

1.5

8.43

8.02

ug/l

0.12

181

634

Non-allergic asthma (mode)

102

263

3.87

34.34

1.6

1.5

8.96

7.34

ug/l

0.19

242

Acute sinusitis

276

1139

2.25

34.32

1.3

1.5

7.35

7.61

ug/l

0.09

247

1023

Sequelae of other external causes

101

6.07

34.25

1.7

1.6

6.29

10.30

ug/l

1.06

Systemic connective tissue disorders

185

698

2.67

33.66

1.3

1.5

8.19

7.88

ug/l

0.05

164

630

Opioids

476

1298

1.91

33.64

1.5

7.76

7.46

ug/l

0.11

440

1162

Non-allergic asthma (mode), excluding more controls

101

263

3.83

33.55

1.6

1.5

9.01

7.46

ug/l

0.17

243

Abdominal and pelvic pain

456

1189

1.93

33.01

1.5

8.02

7.46

ug/l

0.22

413

1083

Sequelae of external causes of morbidity and mortality

146

494

2.98

32.63

1.4

1.5

7.43

8.64

ug/l

0.49

132

441

Childhood asthma (age<16)

173

4.23

32.47

1.6

10.83

5.84

ug/l

0.57

151

Intestinal infectious diseases

536

1704

1.80

32.42

1.4

1.5

7.30

8.14

ug/l

0.61

491

1535

Childhood asthma (age<16), excluding more controls

171

4.23

32.13

1.6

10.90

5.79

ug/l

0.58

150

Other joint disorders

435

1189

1.94

32.08

1.5

7.79

7.58

ug/l

0.07

400

1070

Other systemic involvement of connective tissue (FG)

142

472

2.99

31.90

1.3

1.5

8.92

7.94

ug/l

0.13

125

426

Lumbar disc prolapse

296

1057

2.16

31.86

1.5

8.32

7.54

ug/l

0.23

276

954

Anxiety (asthma-related co-morbidities)

339

1288

2.04

31.82

1.4

1.5

6.33

7.45

ug/l

1.09

306

1162

Soft tissue disorders

481

1329

1.87

31.80

1.4

1.6

7.39

8.05

ug/l

0.34

434

1197

Other external causes of accidental injury

374

922

2.04

31.36

1.4

1.5

6.81

7.84

ug/l

0.57

326

866

Other anxiety disorders

275

1099

2.18

31.16

1.5

7.83

7.50

ug/l

0.07

252

982

Episodal and paroxysmal disorders

516

1456

1.81

30.74

1.5

7.54

7.69

ug/l

0.06

467

1317

Dorsopathies

476

1310

1.85

30.54

1.5

7.17

7.48

ug/l

0.14

439

1177

Neoplasms

384

1033

1.98

30.11

1.7

1.3

8.51

6.43

ug/l

1.09

348

914

Fibromyalgia

189

4.24

30.07

1.5

6.33

7.17

ug/l

0.34

164

Migraine with aura and triptan purchases

124

403

3.11

29.83

1.3

1.4

5.37

6.68

ug/l

1.41

117

353

Somatoform disorder

110

335

3.32

29.45

1.3

1.4

7.25

7.54

ug/l

0.05

103

299

Cervicalgia

116

365

3.20

29.42

1.5

12.11

8.34

ug/l

0.39

104

320

Disorders of eyelid, lacrimal system and orbit

390

1573

1.89

29.16

1.6

1.5

9.89

7.87

ug/l

0.86

350

1431

Nausea and vomiting

138

471

2.89

29.16

1.6

1.5

8.02

7.57

ug/l

0.14

128

423

Chronic laryngitis and laryngotracheitis

211

3.97

29.07

1.2

1.4

6.38

7.97

ug/l

0.74

196

Other noninfective gastroenteritis and colitis

145

521

2.80

29.05

1.6

1.5

8.17

7.90

ug/l

0.06

137

467

External causes of morbidity and mortality

288

662

2.19

28.85

1.4

1.5

6.96

7.96

ug/l

0.52

247

624

Recurrent or chronic depression

223

672

2.34

28.72

1.4

1.6

6.45

8.25

ug/l

1.39

201

614

Hypermobility syndrome

131

4.92

28.63

1.4

5.13

6.31

ug/l

0.63

111

Shoulder lesions

327

979

2.03

28.60

1.5

1.6

8.93

8.45

ug/l

0.16

308

881

Syncope and collapse

186

643

2.49

28.53

1.4

1.6

9.42

8.40

ug/l

0.26

165

586

Persons encountering health services for specific procedures and health care

512

1760

1.75

28.44

1.6

1.5

8.62

7.54

ug/l

0.50

464

1596

Accidents

364

922

1.98

28.44

1.4

1.5

7.18

7.84

ug/l

0.30

318

866

Special screening examination for infectious and parasitic diseases

120

277

3.21

28.19

1.3

1.6

4.97

7.36

ug/l

2.48

112

239

Irritable bowel syndrome

160

615

2.62

28.16

1.4

1.5

5.26

7.80

ug/l

3.40

147

556

Certain infectious and parasitic diseases

456

1252

1.83

28.11

1.4

1.5

7.04

7.68

ug/l

0.37

411

1119

Rosacea

221

3.85

28.09

1.3

1.5

5.52

8.63

ug/l

1.98

192

Cardiovascular diseases

358

979

1.97

28.08

1.3

1.6

6.32

7.37

ug/l

0.50

320

887

Injury, poisoning and certain other consequences of external causes

235

500

2.36

28.07

1.4

1.5

8.16

7.65

ug/l

0.15

200

475

Symptoms and signs involving the digestive system and abdomen

438

1189

1.85

28.02

1.5

7.88

7.46

ug/l

0.16

403

1083

Seborrhoeic dermatitis

126

4.90

27.84

1.4

1.8

6.44

10.71

ug/l

1.43

109

Disorders of lacrimal system

207

900

2.31

27.69

1.6

1.5

10.58

8.21

ug/l

0.54

184

816

Other functional intestinal disorders

212

861

2.29

27.67

1.5

7.15

8.55

ug/l

0.65

196

788

Other systemic involvement of connective tissue

145

536

2.72

27.59

1.3

1.6

8.88

8.27

ug/l

0.08

128

482

Rash and other nonspecific skin eruption

160

4.37

27.36

1.7

1.6

7.44

8.54

ug/l

0.29

139

Viral infections characterized by skin and mucous membrane lesions

407

1927

1.81

27.29

1.6

1.5

8.26

7.94

ug/l

0.11

375

1741

Other benign neoplasms of skin

174

707

2.47

27.28

1.5

7.85

8.20

ug/l

0.12

167

629

Diarrhoea and gastroenteritis of presumed infectious origin

338

1597

1.91

27.15

1.6

1.5

8.06

7.99

ug/l

0.02

318

1438

Enlarged lymph nodes

251

3.57

26.87

1.6

1.5

6.65

7.81

ug/l

0.41

224

Spondylosis

220

800

2.25

26.75

1.5

1.6

10.76

8.21

ug/l

0.58

198

724

Intestinal infectious diseases

438

1882

1.77

26.69

1.5

8.01

7.98

ug/l

0.01

406

1698

Codeine

427

1276

1.82

26.65

1.3

1.5

7.44

7.52

ug/l

0.02

391

1143

Depression

454

1751

1.76

26.61

1.4

1.5

7.04

8.17

ug/l

0.79

411

1581

Noninfective enteritis and colitis

231

1071

2.16

26.53

1.6

1.5

8.14

7.54

ug/l

0.19

213

968

Nerve, nerve root and plexus disorders

467

1634

1.76

26.44

1.4

1.5

8.58

7.97

ug/l

0.21

426

1480

Mycoses

145

551

2.65

26.16

1.3

1.5

7.54

8.06

ug/l

0.21

132

487

Other disorders of lacrimal gland

176

734

2.41

26.10

1.6

1.5

11.11

8.04

ug/l

0.64

158

662

Concussion

246

948

2.13

26.02

1.4

1.6

8.71

7.94

ug/l

0.24

220

859

Complications of procedures, not elsewhere classified

359

1606

1.86

25.92

1.6

1.5

9.72

7.77

ug/l

0.76

325

1459

Arthropathies

426

1191

1.82

25.87

1.4

1.5

7.33

7.57

ug/l

0.10

384

1072

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

264

1284

2.04

25.84

1.7

1.4

9.66

8.06

ug/l

0.47

239

1172

COPD/asthma/ILD related infections

469

1337

1.76

25.64

1.4

1.5

7.28

7.70

ug/l

0.21

416

1217

COPD/asthma related infections

469

1337

1.76

25.64

1.4

1.5

7.28

7.70

ug/l

0.21

416

1217

Other condition

299

3.28

25.55

1.4

1.5

7.51

8.05

ug/l

0.18

261

Antihypertensive medication - note that there are other indications

345

953

1.93

25.26

1.3

1.5

6.12

7.66

ug/l

0.87

308

859

Neurological diseases, wide definition

167

317

2.66

25.22

1.2

1.7

5.20

7.06

ug/l

2.44

145

288

Viral infections characterized by skin and mucous membrane lesions

208

946

2.21

25.14

1.9

1.5

9.55

7.57

ug/l

0.52

198

851

Rheumatism, unspecified

240

3.53

24.92

1.6

9.06

8.72

ug/l

0.05

213

Certain disorders involving the immune mechanism

114

394

2.92

24.69

1.8

1.5

10.35

7.80

ug/l

0.39

104

351

Spondylopathies

315

968

1.95

24.67

1.4

1.5

10.43

7.75

ug/l

0.76

287

868

Any reimbursement code in KELA

307

772

2.00

24.63

1.3

1.6

6.05

7.30

ug/l

1.21

264

709

Anaemias

131

302

2.85

24.40

1.8

1.6

10.60

8.47

ug/l

0.34

116

272

Implicit Sepsis

318

1267

1.90

24.26

1.4

1.5

9.62

8.01

ug/l

0.49

285

1148

Parasetamol

343

914

1.91

24.17

1.5

7.75

6.86

ug/l

0.58

301

826

Mood disorders, excluding more controls

424

1453

1.75

23.56

1.4

1.5

7.28

8.34

ug/l

0.66

384

1310

Pain (limb, back, neck, head abdominally)

299

757

1.98

23.53

1.5

1.6

7.53

7.48

ug/l

0.02

268

685

Rotator cuff syndrome

244

853

2.06

23.20

1.7

1.6

9.69

8.90

ug/l

0.21

229

772

Neurological diseases

395

1109

1.79

23.06

1.5

1.6

7.68

7.79

ug/l

0.04

349

1001

Nasal polyp

285

3.18

22.69

1.4

1.5

8.48

7.83

ug/l

0.15

264

Implicit Sepsis

349

1416

1.81

22.69

1.4

1.5

9.55

7.76

ug/l

0.64

316

1286

Mood disorders

462

1787

1.68

22.60

1.4

1.5

7.13

8.20

ug/l

0.75

418

1613

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

162

322

2.53

22.42

1.4

1.6

7.22

7.05

ug/l

0.05

140

285

Certain infectious and parasitic diseases

321

849

1.90

22.33

1.5

1.6

7.99

8.02

ug/l

0.01

283

758

Dysphagia

108

383

2.84

22.32

1.4

1.6

6.84

9.13

ug/l

1.05

341

Mood [affective] disorders

460

1787

1.67

22.29

1.4

1.5

7.14

8.20

ug/l

0.74

416

1614

Symptoms and signs involving the nervous and musculoskeletal systems

253

1307

1.94

21.78

1.5

9.84

8.05

ug/l

0.44

230

1184

Deviated nasal septum

135

542

2.50

21.77

1.4

1.6

6.49

8.36

ug/l

1.50

111

505

Vocal cord dysfunction

216

3.35

21.34

1.5

6.83

8.17

ug/l

0.44

196

Candidiasis

154

664

2.33

21.31

1.4

1.5

8.79

7.69

ug/l

0.27

142

592

Acute bronchitis

180

812

2.18

21.19

1.5

10.16

7.90

ug/l

0.44

163

732

Other nutritional deficiencies

315

1655

1.80

21.12

1.4

1.5

6.85

8.08

ug/l

1.11

284

1492

Other medical care

196

837

2.11

20.96

1.7

1.4

10.20

8.32

ug/l

0.37

181

757

Cervicobrachial syndrome

112

419

2.69

20.95

1.5

6.87

8.17

ug/l

0.42

106

374

Finngen Rheumatological endpoints

428

1453

1.68

20.56

1.5

8.18

7.73

ug/l

0.16

381

1314

Depression medications

162

338

2.42

20.52

1.3

1.6

6.41

8.23

ug/l

0.53

140

301

Migraine, single triptan purchase ok & required. ICD-code if available is included

372

1468

1.72

20.27

1.3

1.5

7.14

7.77

ug/l

0.21

340

1315

Triptan medication for migraine, single purchase ok

372

1468

1.72

20.27

1.3

1.5

7.14

7.77

ug/l

0.21

340

1315

Enthesopathies of lower limb, excluding foot

111

421

2.65

20.23

1.5

6.91

8.26

ug/l

0.66

372

Osteopathies and chondropathies

241

1167

1.93

20.20

1.9

1.4

12.50

7.74

ug/l

1.43

220

1065

Infections of the skin and subcutaneous tissue

265

1413

1.86

20.15

1.5

9.34

7.79

ug/l

0.38

231

1285

Sleep disorders (combined)

483

1564

1.62

20.07

1.4

1.5

6.90

8.42

ug/l

1.60

434

1422

Other heart diseases, wide

419

1538

1.67

20.04

1.6

1.5

8.14

7.40

ug/l

0.37

375

1406

Persons encountering health services for other counselling and medical advice, not elsewhere classified

476

1596

1.62

19.94

1.4

1.5

7.98

7.99

ug/l

0.00

439

1446

Migraine without aura

127

518

2.47

19.94

1.4

5.58

6.72

ug/l

0.96

121

464

Factors influencing health status and contact with health services

103

170

3.05

19.85

1.4

1.6

9.03

8.03

ug/l

0.20

156

Symptoms and signs involving cognition, perception, emotional state and behaviour

414

1704

1.66

19.80

1.5

8.23

7.80

ug/l

0.15

379

1539

Other acute lower respiratory infections

230

1133

1.94

19.69

1.6

10.71

7.69

ug/l

0.66

208

1023

Other arthrosis

199

661

2.09

19.68

1.6

7.55

9.10

ug/l

0.53

183

601

Disorders of other endocrine glands

205

1008

2.01

19.45

1.8

1.5

10.68

7.37

ug/l

0.95

186

909

Other general symptoms and signs

4.86

19.40

1.6

1.7

4.71

6.66

ug/l

0.87

Condition for Implicit Sepsis (Organ dysfunction codes)

356

1468

1.72

19.38

1.5

9.53

7.65

ug/l

0.70

323

1331

Other reaction to severe stress, and adjustment disorders

195

960

2.04

19.38

1.4

1.5

7.46

7.69

ug/l

0.06

180

862

Dizziness and giddiness

316

1425

1.76

19.32

1.5

8.90

8.06

ug/l

0.24

287

1292

Gastrointestinal diseases

279

742

1.89

19.22

1.4

1.5

6.47

7.48

ug/l

0.63

244

670

Cervical disc disorders

143

627

2.29

19.06

1.2

1.6

9.43

8.36

ug/l

0.16

136

567

Persons encountering health services in other circumstances, wide

494

1597

1.60

19.06

1.4

1.5

7.62

7.98

ug/l

0.14

444

1447

Diseases of the musculoskeletal system and connective tissue

243

622

1.96

18.76

1.4

1.6

6.65

7.03

ug/l

0.17

212

554

Cardiovascular diseases (excluding rheumatic etc)

336

1109

1.75

18.70

1.4

1.5

7.18

7.01

ug/l

0.06

301

997

Depression or dysthymia

290

877

1.83

18.61

1.5

1.6

8.11

8.64

ug/l

0.18

263

802

Autoimmune diseases related-to ILD

366

1882

1.67

18.58

1.4

1.5

6.67

8.05

ug/l

1.37

328

1708

Voice disturbances

128

544

2.37

18.38

1.5

7.51

8.26

ug/l

0.20

116

484

Intracranial trauma

256

970

1.86

18.29

1.5

1.6

9.37

7.98

ug/l

0.42

231

880

Condition for Implicit Sepsis (Organ dysfunction codes)

379

1581

1.66

18.08

1.5

9.45

7.43

ug/l

0.80

341

1441

Other diseases of lip and oral mucosa

178

874

2.05

17.87

1.4

1.5

5.82

8.00

ug/l

3.00

157

791

Abnormal findings on examination of blood, without diagnosis

178

800

2.05

17.72

1.9

1.5

11.73

8.42

ug/l

0.86

166

722

Mycoses

370

1966

1.64

17.72

1.5

8.27

7.95

ug/l

0.10

338

1777

Symptoms and signs involving speech and voice

147

673

2.20

17.71

1.5

10.45

8.38

ug/l

0.31

133

598

Childhood allergy (age < 16)

105

335

2.60

17.69

1.7

1.4

10.26

5.26

ug/l

0.68

294

Haemorrhoids and perianal venous thrombosis

131

571

2.30

17.65

1.3

1.6

9.81

9.14

ug/l

0.08

118

522

Sleep apnoea

381

1500

1.65

17.62

1.4

1.5

8.39

8.38

ug/l

0.00

335

1370

Behavioural syndromes associated with physiological disturbances and physical factors

405

1782

1.62

17.61

1.4

1.5

6.00

8.53

ug/l

4.63

374

1608

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

239

1302

1.84

17.55

1.6

1.5

9.42

8.06

ug/l

0.35

216

1181

D07AA Corticosteroids, weak (group I)

370

2.64

17.51

1.4

5.80

6.95

ug/l

0.80

329

Other antidepressants

429

1364

1.61

17.41

1.5

1.6

7.98

8.64

ug/l

0.23

388

1235

Noninfectious colitis NAS

267

2.95

17.33

1.4

6.20

8.40

ug/l

1.43

230

Triptan medication for migraine, min. 3 purchases

298

1312

1.74

17.33

1.4

1.5

5.70

7.66

ug/l

2.31

273

1173

ILD medications: azathioprine

251

3.01

17.33

1.1

1.5

5.62

8.00

ug/l

1.65

224

Visual disturbances and blindness

219

1167

1.88

17.31

1.5

9.97

8.32

ug/l

0.34

201

1057

Primary_lymphoid and hematopoietic malignant neoplasms

385

2.59

17.23

3.1

1.4

14.82

8.62

ug/l

2.25

343

Melanocytic naevi of upper limb, including shoulder

6.54

17.18

1.8

1.5

14.58

7.00

ug/l

0.50

Used for control exclusion in common control thyroid runs

446

1416

1.59

17.16

1.4

1.6

7.67

7.57

ug/l

0.03

395

1290

All influenza

114

475

2.41

17.13

1.6

1.5

9.65

7.75

ug/l

0.25

101

426

Injuries to the ankle and foot

327

1742

1.67

16.97

1.4

1.5

9.07

7.63

ug/l

0.36

290

1571

Cardiac arrhythmias

294

1095

1.75

16.95

1.7

1.5

8.52

7.10

ug/l

0.60

261

991

Symptoms and signs concerning food and fluid intake

149

3.65

16.95

1.7

1.5

9.72

7.53

ug/l

0.26

132

Benign neoplasm: Colon

191

933

1.96

16.94

1.5

1.6

10.25

8.85

ug/l

0.27

181

845

Diseases of the eye and adnexa

365

1096

1.67

16.87

1.4

1.6

6.56

8.04

ug/l

1.17

335

979

Disorders of synovium and tendon

221

1037

1.87

16.83

1.3

1.6

7.82

8.29

ug/l

0.10

202

934

Disorders of the thyroid gland

402

1634

1.61

16.81

1.4

1.5

8.55

7.82

ug/l

0.26

362

1483

Endocrine, nutritional and metabolic diseases

373

1143

1.66

16.70

1.4

1.5

7.25

7.17

ug/l

0.04

331

1034

Polyarthrosis

276

2.81

16.69

1.6

8.91

8.88

ug/l

0.00

246

Erysipelas

210

983

1.90

16.65

1.4

1.5

10.14

8.10

ug/l

0.62

191

890

Other arrhythmias

276

1189

1.76

16.61

1.7

1.5

9.37

7.79

ug/l

0.45

248

1084

Diseases of salivary glands

153

731

2.10

16.58

1.4

1.5

6.04

7.91

ug/l

2.08

143

651

Autoimmune diseases excluding thyroid diseases

441

1528

1.58

16.56

1.4

1.6

8.51

7.81

ug/l

0.25

399

1392

Obesity and other hyperalimentation

288

1624

1.71

16.56

1.3

1.5

6.78

8.09

ug/l

1.30

260

1464

Visual disturbances

206

1093

1.89

16.56

1.5

10.08

8.27

ug/l

0.36

188

995

Codeine or tramadol medication

474

1675

1.55

16.55

1.4

1.5

8.16

7.75

ug/l

0.14

433

1512

Obesity

287

1620

1.71

16.53

1.3

1.5

6.79

8.10

ug/l

1.29

259

1462

Migraine without aura and triptan purchases

104

424

2.47

16.45

1.4

5.30

6.56

ug/l

1.35

373

Sleep disorders

386

1743

1.60

16.40

1.4

1.5

6.10

8.57

ug/l

4.23

357

1574

Sleep apnoea, including avohilmo

405

1576

1.59

16.34

1.4

1.5

7.98

8.20

ug/l

0.10

360

1442

Subjective visual disturbances

122

536

2.29

16.30

1.4

1.5

6.84

7.74

ug/l

0.35

112

476

Benign neoplasm of colon, rectum, anus and anal canal

225

1065

1.84

16.21

1.5

10.67

8.44

ug/l

0.54

212

967

Covid-19 confirmed case

149

712

2.10

16.13

1.4

1.5

8.90

8.28

ug/l

0.13

135

639

Disorders of thyroid, IBD co-morbidities

205

2.86

16.10

1.6

1.7

12.21

7.48

ug/l

0.44

185

Internal derangement of knee

152

729

2.08

16.08

1.4

1.6

6.23

8.61

ug/l

1.97

144

654

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

415

1722

1.57

15.94

1.4

1.5

8.87

7.52

ug/l

0.53

359

1575

Pain and other conditions associated with female genital organs and menstrual cycle

123

500

2.28

15.93

1.4

1.3

5.69

6.37

ug/l

0.50

114

443

Spinal stenosis

167

623

2.04

15.92

1.5

1.6

12.99

8.50

ug/l

0.94

150

565

Other symptoms and signs involving the digestive system and abdomen

280

2.80

15.91

1.4

1.6

7.17

8.41

ug/l

0.34

243

Acute pharyngitis

322

2.67

15.90

1.6

6.16

7.10

ug/l

0.33

284

In situ neoplasms

153

744

2.07

15.83

1.4

1.5

7.91

8.45

ug/l

0.14

145

668

Pain in thoracic spine

292

2.76

15.83

1.6

7.12

8.72

ug/l

0.57

256

Viral warts

115

501

2.31

15.70

1.9

1.5

10.78

7.06

ug/l

0.65

106

441

Provisional assignment of new diseases of uncertain etiology

224

1241

1.81

15.62

1.4

1.5

7.79

8.14

ug/l

0.10

203

1122

Infective dermatitis

149

3.52

15.50

1.5

1.6

6.96

10.37

ug/l

0.96

129

Hypothyroidism (congenital or acquired)

130

320

2.30

15.50

1.5

1.7

8.80

8.36

ug/l

0.05

116

287

Obesity, other/unspecified

170

866

1.97

15.48

1.4

1.5

6.79

7.48

ug/l

0.37

153

778

Codes for special purposes

224

1245

1.80

15.46

1.4

1.5

7.79

8.15

ug/l

0.11

203

1126

Azathioprine

268

2.82

15.45

1.1

1.5

5.62

7.88

ug/l

1.71

237

Autoimmune diseases excluding thyroid diseases, strict definition

422

1478

1.57

15.43

1.4

1.5

8.46

7.50

ug/l

0.36

380

1348

Transport accidents

182

811

1.94

15.35

1.4

1.6

10.26

8.09

ug/l

0.38

163

762

Autoimmune diseases

463

1535

1.54

15.31

1.4

1.6

7.87

7.81

ug/l

0.02

412

1396

Other symptoms and signs involving the nervous and musculoskeletal systems

178

927

1.93

15.18

1.5

8.48

7.71

ug/l

0.20

159

833

Hypertensive diseases (excluding secondary)

246

798

1.80

15.18

1.4

1.5

6.67

7.59

ug/l

0.54

224

720

Implicit bacterial Sepsis

154

653

2.04

15.12

1.4

1.5

12.33

8.42

ug/l

0.69

141

586

Dislocation, sprain and strain of joints and ligaments at neck level

359

2.53

14.96

1.1

1.4

7.47

7.08

ug/l

0.05

315

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

190

1012

1.88

14.93

1.4

9.14

6.85

ug/l

0.51

171

911

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

238

1215

1.76

14.87

1.5

10.86

8.37

ug/l

0.61

218

1107

354

1337

1.61

14.71

1.7

1.5

11.31

7.70

ug/l

1.19

312

1217

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

354

1337

1.61

14.71

1.7

1.5

11.31

7.70

ug/l

1.19

312

1217

Other bacterial diseases

367

1561

1.58

14.68

1.6

1.5

10.94

7.58

ug/l

1.41

329

1426

Temporomandibular joint disorders, including avohilmo

227

1271

1.77

14.67

1.3

1.5

5.98

7.62

ug/l

1.40

204

1138

Polyarthropathies

255

958

1.74

14.62

1.6

1.5

10.24

7.93

ug/l

0.64

232

865

Panic disorder

357

2.51

14.62

1.3

1.4

5.71

6.56

ug/l

0.38

316

Hypothyroidism, levothyroxine purchases

127

319

2.26

14.53

1.2

1.7

5.97

8.37

ug/l

0.83

113

286

Hypothyroidism and >3 levothyroxin purchases

127

319

2.26

14.53

1.2

1.7

5.97

8.37

ug/l

0.83

113

286

Haemorrhage from respiratory passages

119

486

2.21

14.52

1.4

1.5

8.89

8.15

ug/l

0.17

107

437

Candidiasis

289

2.69

14.49

1.3

1.5

7.30

8.07

ug/l

0.21

252

Persons encountering health services in other circumstances

175

920

1.90

14.31

1.3

1.5

6.96

8.19

ug/l

0.35

147

830

Erysipelas

267

1207

1.69

14.23

1.4

1.5

9.72

8.03

ug/l

0.61

242

1098

Oxicams

188

2.67

14.22

1.3

1.6

6.65

8.76

ug/l

0.79

177

Dentofacial anomalies [including malocclusion]

324

1628

1.60

14.06

1.3

1.6

5.91

7.87

ug/l

2.71

288

1472

Implicit bacterial Sepsis

138

596

2.06

13.95

1.4

1.5

13.08

8.48

ug/l

0.75

127

539

Inflammatory diseases of female pelvic organs

291

1302

1.65

13.92

1.5

6.93

7.85

ug/l

0.30

257

1175

Other bacterial diseases

405

1682

1.53

13.84

1.5

10.36

7.42

ug/l

1.34

362

1532

Intracranial injury

237

1308

1.72

13.84

1.6

1.5

9.14

8.07

ug/l

0.30

214

1183

Cystitis

357

1350

1.58

13.69

1.4

1.5

7.86

7.75

ug/l

0.03

325

1225

Infections, IBD-co-morbidities

172

2.88

13.68

1.8

1.7

9.56

8.03

ug/l

0.24

156

Any event in cancer register

371

1402

1.56

13.66

2.0

1.3

10.46

7.35

ug/l

1.68

346

1247

Hypertension, essential

316

1105

1.62

13.52

1.7

1.5

8.45

7.82

ug/l

0.25

285

998

Oter anti-inflammatory and antirheumatic agents, non-steroids

149

2.83

13.50

1.4

1.7

8.43

9.56

ug/l

0.22

139

Other enthesopathies

123

587

2.10

13.47

1.2

1.6

5.46

8.68

ug/l

2.96

112

528

Other disorders of bone

102

453

2.27

13.38

1.3

1.4

5.74

7.28

ug/l

1.39

401

Diaphragmatic hernia

134

664

2.03

13.26

1.6

7.46

9.93

ug/l

1.40

128

595

Exclusions for E4_PCOS_BROAD

381

2.38

13.18

1.7

1.5

10.97

7.74

ug/l

0.36

332

Non-selective monoamine reuptake inhibitors

143

699

1.98

13.17

1.6

7.57

9.77

ug/l

1.12

131

636

Injuries to the neck

112

521

2.16

13.12

1.2

1.5

7.16

7.19

ug/l

0.00

463

Arthrosis

253

814

1.71

13.11

1.6

1.5

7.91

8.40

ug/l

0.15

228

732

Generalized anxiety disorder

395

2.34

13.08

1.3

1.4

6.34

6.60

ug/l

0.08

350

Congenital malformations and deformations of the musculoskeletal system

269

2.65

13.01

1.9

1.6

10.54

7.13

ug/l

0.29

233

Hypertension

326

1161

1.59

12.82

1.6

1.5

8.06

7.69

ug/l

0.14

295

1052

Hypertensive diseases

326

1162

1.59

12.79

1.6

1.5

8.06

7.69

ug/l

0.14

295

1053

Other disorders of patella

338

2.44

12.76

1.4

1.5

6.27

6.87

ug/l

0.29

300

Any mental disorder

439

1477

1.49

12.68

1.4

1.5

7.01

8.29

ug/l

0.90

396

1334

Soft tissue disorders related to use, overuse and pressure

103

470

2.20

12.67

1.4

1.6

6.51

8.24

ug/l

1.00

427

Bacterial Sepsis

156

704

1.90

12.52

1.4

1.5

12.71

8.53

ug/l

0.76

141

631

Oxycodone

131

592

2.01

12.48

1.6

13.40

8.42

ug/l

0.77

119

536

Insomnia

363

1745

1.52

12.34

1.4

1.5

6.17

8.47

ug/l

3.65

335

1575

Obesity due to excess calories

210

1230

1.71

12.29

1.2

1.5

6.94

7.92

ug/l

0.70

189

1116

Other heart diseases

219

830

1.73

12.27

1.8

1.5

9.77

7.53

ug/l

0.77

201

752

Ovarian cyst

174

539

1.87

12.25

1.4

6.10

6.95

ug/l

0.63

162

478

Malignant neoplasm, wide definition for exclusion

339

1283

1.55

12.23

1.8

1.5

9.32

7.80

ug/l

0.63

316

1139

Nonorganic sleeping disorders, excluding more controls

415

2.25

12.11

1.5

5.91

7.11

ug/l

0.73

373

Heartburn

180

2.96

12.07

1.3

1.4

6.10

7.21

ug/l

0.54

154

Leisure time condition

386

2.29

11.95

1.4

1.5

7.25

7.73

ug/l

0.16

336

Benzodiazepine use

398

1860

1.48

11.70

1.5

8.40

7.83

ug/l

0.18

359

1686

Other and unspecified tonsillitis

153

694

1.86

11.52

1.4

1.5

6.42

7.10

ug/l

0.29

135

617

Follicular cysts of skin and subcutaneous tissue

349

2.33

11.48

1.2

1.6

6.22

8.28

ug/l

1.58

312

Personality disorders, excluding more controls

121

611

1.99

11.44

1.3

1.5

7.54

6.96

ug/l

0.11

110

547

Hypothyroidism, strict autoimmune

290

1214

1.57

11.42

1.3

1.5

6.90

7.68

ug/l

0.59

258

1103

Cervicocranial syndrome

197

2.81

11.40

1.4

1.6

7.74

9.35

ug/l

0.41

173

Bacterial infection, other or unspecified

182

906

1.75

11.25

1.4

1.5

13.01

7.98

ug/l

1.11

161

822

Superficial injury of ankle and foot

274

2.50

11.18

1.3

1.4

4.97

6.67

ug/l

1.45

241

Second line medication for Crohn's disease

232

1436

1.62

11.02

1.5

1.6

8.04

8.43

ug/l

0.09

208

1308

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

433

2.16

10.97

1.2

1.5

4.95

7.16

ug/l

2.32

384

Gonarthrosis

209

699

1.71

10.97

1.4

1.6

7.75

8.96

ug/l

0.51

184

627

Lichen simplex chronicus and prurigo

3.91

10.84

1.2

1.8

12.60

10.00

ug/l

0.27

Herpesviral [herpes simplex] infections

118

603

1.97

10.83

1.4

1.5

6.23

7.27

ug/l

0.71

106

536

Sequelae with surgical and medical care as external cause

373

2.24

10.69

1.5

8.59

8.77

ug/l

0.04

331

Other disorders of urethra and urinary system

272

1260

1.56

10.56

1.5

10.07

7.92

ug/l

0.57

243

1143

L04AX Other immunosuppressants

224

1390

1.62

10.55

1.4

1.6

7.48

8.56

ug/l

0.29

201

1264

Diseases of the ear and mastoid process

471

1673

1.42

10.52

1.5

6.92

8.07

ug/l

1.05

423

1515

Bacterial infection, other or unspecified

199

1008

1.67

10.50

1.4

1.5

12.29

7.77

ug/l

1.09

177

920

Abnormal findings on diagnostic imaging of lung

152

814

1.79

10.49

1.7

1.5

12.98

8.77

ug/l

0.69

138

734

Carpal tunnel syndrome

228

1249

1.61

10.49

1.4

1.6

8.83

8.35

ug/l

0.12

208

1130

Ethmoidectomy

253

2.51

10.46

1.3

1.6

8.39

8.10

ug/l

0.05

224

Deforming dorsopathies

107

535

2.01

10.45

1.7

1.5

8.82

7.88

ug/l

0.21

101

479

Cholecystectomy

260

1438

1.56

10.44

1.5

8.26

8.33

ug/l

0.02

234

1302

Malignant neoplasm

316

1235

1.52

10.38

1.7

1.5

7.95

7.92

ug/l

0.02

295

1095

Hypothyroidism, other/unspecified

347

1549

1.48

10.21

1.3

1.5

7.92

7.80

ug/l

0.04

309

1406

Impingement syndrome of shoulder

420

2.13

10.16

1.3

1.7

8.19

9.95

ug/l

0.47

378

Conjunctivitis (acute, non atopic)

122

643

1.90

10.12

1.3

1.6

5.58

7.46

ug/l

2.41

114

575

Constipation

329

1539

1.48

9.99

1.4

1.5

7.41

8.19

ug/l

0.50

294

1404

Symptoms and signs involving the urinary system

266

1314

1.54

9.99

1.5

7.35

8.62

ug/l

0.68

241

1194

Melanoma in situ

4.08

9.98

2.2

1.5

15.57

9.95

ug/l

0.32

Tonsillectomy and adenotomy

271

1227

1.54

9.89

1.4

1.5

5.50

7.38

ug/l

2.78

249

1097

Influenza and pneumonia

421

1894

1.42

9.89

1.7

1.5

10.44

7.39

ug/l

1.21

374

1724

Other neurological diseases

242

1212

1.57

9.86

1.3

1.5

10.73

8.00

ug/l

0.76

222

1099

Convulsions, not elsewhere classified

407

2.12

9.82

1.7

1.5

14.46

7.26

ug/l

0.73

369

Other and unspecified diseases of blood and blood-forming organs

4.97

9.82

2.5

1.2

11.31

5.89

ug/l

1.28

Hyperkinetic disorders, excluding more controls

261

2.40

9.76

1.6

1.5

5.43

5.38

ug/l

0.03

229

Psychiatric diseases

381

1318

1.45

9.74

1.4

1.6

7.28

8.45

ug/l

0.65

341

1195

Diseases of the digestive system

155

890

1.74

9.68

1.7

1.5

12.27

8.45

ug/l

1.04

140

804

Caries of enamel

361

1808

1.44

9.65

1.3

1.5

5.98

8.15

ug/l

4.13

329

1629

Excessive, frequent and irregular menstruation

179

572

1.72

9.63

1.6

1.4

7.42

6.82

ug/l

0.12

163

511

Other diseases of urinary system

388

1522

1.44

9.62

1.4

1.5

8.05

7.82

ug/l

0.07

350

1378

Diseases of external ear

129

707

1.83

9.61

1.4

1.6

6.09

8.25

ug/l

2.15

117

636

Hypothyreosis and Thyroxine purchase for inclusion criteria

359

1630

1.45

9.59

1.5

8.91

7.80

ug/l

0.39

319

1482

Injuries to the abdomen, lower back, lumbar spine and pelvis

144

807

1.77

9.59

1.7

1.5

11.67

7.46

ug/l

1.06

133

727

Zoster [herpes zoster]

168

980

1.69

9.52

1.7

1.5

8.31

8.76

ug/l

0.12

156

887

Striking against or struck by other objects

139

781

1.78

9.52

1.7

1.5

11.80

7.10

ug/l

0.80

128

701

Other inflammation of eyelid

253

2.43

9.49

1.5

7.86

8.62

ug/l

0.19

223

Selective serotonin reuptake inhibitors

378

1372

1.44

9.44

1.4

1.6

7.82

8.61

ug/l

0.28

339

1243

Meniscus derangement

178

712

1.69

9.38

1.5

1.6

9.13

8.86

ug/l

0.04

165

646

Congenital malformations and deformations of the musculoskeletal system

231

2.47

9.23

1.4

1.5

5.36

6.75

ug/l

0.75

202

Unspecified fall

184

1110

1.64

9.22

1.6

1.5

8.28

8.43

ug/l

0.03

166

1007

Gonarthrosis [arthrosis of knee](FG)

248

928

1.56

9.20

1.3

1.6

7.79

8.89

ug/l

0.55

219

843

Disorders of vestibular function (Vertigo)

161

937

1.69

9.19

1.4

1.5

6.91

9.06

ug/l

1.37

144

855

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

191

732

1.65

9.17

1.5

7.57

7.61

ug/l

0.01

177

655

Other specified/unspecified arthritis

492

1.98

9.16

1.7

1.6

13.28

9.10

ug/l

0.47

439

Diverticular disease of intestine

232

944

1.57

9.15

1.4

1.6

6.80

9.15

ug/l

2.20

216

864

FESS (DNB20)

246

2.41

9.10

1.3

1.6

8.39

8.20

ug/l

0.03

219

Chondropathies

328

2.21

9.05

1.2

1.4

5.34

7.45

ug/l

1.85

286

Lyme disease

117

636

1.85

8.99

1.3

1.5

5.97

7.88

ug/l

2.12

111

565

Polyneuropathies and other disorders of the peripheral nervous system

350

2.15

8.88

1.3

1.5

15.76

8.72

ug/l

0.60

309

Other diseases of anus and rectum

102

533

1.92

8.79

1.7

1.6

10.79

9.29

ug/l

0.23

488

Hernia of abdominal wall, postoperative

288

2.27

8.73

1.7

1.3

8.25

7.50

ug/l

0.14

254

Falls/tendency to fall

436

1578

1.39

8.72

1.4

1.5

7.09

7.56

ug/l

0.27

392

1433

Spirochaetal infections, other/unspecified

117

643

1.83

8.70

1.3

1.5

5.97

7.89

ug/l

2.15

111

572

Percutaneous Coronary Intervention

264

1073

1.51

8.68

1.4

1.6

8.62

8.38

ug/l

0.09

239

981

Other spirochaetal diseases

119

658

1.82

8.67

1.3

1.5

5.94

7.90

ug/l

2.30

113

587

Other spirochaetal diseases

117

644

1.82

8.65

1.3

1.5

5.97

7.88

ug/l

2.14

111

573

Viral and other specified intestinal infections

126

683

1.79

8.65

1.5

1.4

8.13

6.67

ug/l

0.42

118

606

Injuries to the knee and lower leg

460

1873

1.36

8.58

1.4

1.5

7.23

8.18

ug/l

0.63

405

1707

Hard cardiovascular diseases

289

1166

1.48

8.58

1.4

1.6

7.90

8.37

ug/l

0.21

263

1073

Coronary revascularization (ANGIO or CABG)

264

1075

1.51

8.56

1.4

1.6

8.62

8.38

ug/l

0.09

239

983

Venous thromboembolism

174

1034

1.63

8.56

1.4

1.5

7.27

8.97

ug/l

1.34

160

938

Other viral diseases

133

761

1.75

8.55

1.5

1.4

6.57

6.68

ug/l

0.05

122

683

Other arthritis (FG)

113

618

1.83

8.54

1.6

12.31

8.04

ug/l

0.60

104

560

Fall on same level

457

1830

1.37

8.52

1.4

1.5

8.46

7.54

ug/l

0.34

406

1663

Other disorders of fluid, electrolyte and acid-base balance

102

513

1.90

8.52

1.2

1.6

8.76

9.65

ug/l

0.22

466

Endometriosis

150

509

1.73

8.49

1.5

1.4

7.13

7.11

ug/l

0.01

133

452

Other viral diseases, not elsewhere classified

430

2.00

8.44

1.4

1.5

6.09

7.24

ug/l

0.63

379

Artrosis, including avohilmo

298

1111

1.47

8.42

1.5

6.85

8.11

ug/l

0.98

269

1006

Other and unspecified polyneuropathies, also in other diseases

306

2.20

8.39

1.3

1.5

16.98

8.27

ug/l

0.70

267

Diseases of inner ear

182

1103

1.60

8.32

1.4

1.5

6.80

9.19

ug/l

1.79

165

999

Budesonide

245

2.34

8.25

1.9

1.5

9.01

8.18

ug/l

0.12

216

Unspecified/other endometriosis

221

2.41

8.22

1.3

4.52

5.66

ug/l

1.26

192

Polyuria

390

2.03

8.11

1.5

6.89

8.94

ug/l

0.83

348

Emergency coronary revascularization (for ACS)

270

1111

1.48

8.07

1.4

1.6

8.99

8.64

ug/l

0.13

243

1019

Procreative management

153

768

1.67

8.06

2.0

1.4

10.50

6.49

ug/l

0.84

139

704

Cellulitis

439

1.97

8.04

1.5

11.04

7.88

ug/l

0.52

395

Nonorganic sleeping disorders

488

1.91

8.03

1.5

1.4

5.91

7.02

ug/l

0.67

428

Osteoporosis

403

1.98

7.99

3.1

1.4

19.06

8.18

ug/l

2.07

358

Major coronary heart disease event

273

1120

1.47

7.98

1.5

1.6

9.24

8.44

ug/l

0.30

248

1026

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

132

772

1.72

7.97

1.7

1.5

12.63

7.75

ug/l

0.83

118

696

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

112

627

1.79

7.88

1.5

6.61

7.48

ug/l

0.38

101

567

Disease of hard tissues of teeth, NOS

196

646

1.59

7.87

1.3

1.5

6.63

8.05

ug/l

0.95

179

594

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

122

702

1.74

7.82

1.6

1.5

6.78

7.09

ug/l

0.13

113

630

Genitourinary diseases

217

702

1.55

7.80

1.6

1.5

7.60

6.89

ug/l

0.37

192

637

Menorrhagia

141

455

1.72

7.79

1.3

1.4

5.82

7.42

ug/l

1.39

132

405

Vulvovaginal ulceration/inflammation in other diseases

144

2.73

7.77

2.1

1.6

14.31

7.38

ug/l

0.34

123

Unstable angina pectoris

100

423

1.87

7.75

1.5

1.6

10.50

9.10

ug/l

0.28

391

Coxibs

241

1.99

7.74

1.5

1.7

6.84

9.29

ug/l

0.63

225

Heart failure, not strict

237

1075

1.50

7.74

1.6

1.5

10.48

8.63

ug/l

0.48

215

983

Viral and other specified intestinal infections

512

1.86

7.63

1.5

8.96

6.85

ug/l

0.48

452

Other hammer toe(s) (acquired)

228

2.27

7.53

1.9

1.6

11.32

9.20

ug/l

0.20

203

Nontoxic multinodular goitre

347

2.05

7.52

1.4

1.6

6.90

9.02

ug/l

1.01

305

Injuries to the wrist and hand

382

1944

1.36

7.44

1.5

7.52

8.06

ug/l

0.26

350

1757

Lichen ruber planus, wide definition including periferal and oral lichen planus

413

1.94

7.29

1.3

1.6

6.21

8.65

ug/l

1.93

368

Chronic gastritis

406

1.95

7.28

1.5

1.6

8.79

9.45

ug/l

0.14

361

Inflammatory disease of uterus

352

2.03

7.26

1.9

1.4

10.66

6.99

ug/l

0.30

310

Rheumatoid arthritis

100

496

1.81

7.23

1.5

1.6

8.60

9.52

ug/l

0.16

450

Papulosquamous disorders

139

850

1.64

7.14

1.3

1.5

6.99

8.09

ug/l

0.61

126

772

Care involving use of rehabilitation procedures

226

1413

1.47

7.14

1.8

1.5

11.32

7.89

ug/l

0.94

204

1282

Early onset COPD, excluding more controls

268

2.17

7.11

1.6

1.7

10.17

9.50

ug/l

0.09

248

Amenorrhoea

157

2.57

7.09

2.1

1.2

20.10

5.48

ug/l

0.76

136

Other diseases of the digestive system

524

1.82

7.06

1.8

1.6

14.11

9.07

ug/l

0.81

475

Other/unspecified enthesopathies of lower limb, excluding foot

129

2.73

7.02

1.4

1.6

5.58

9.09

ug/l

1.59

113

Hypothyroidism, strict autoimmune, 3 medication purchases required

316

1536

1.39

6.98

1.3

1.5

6.77

7.80

ug/l

0.91

280

1398

Other and unspecified disorders of skin and subcutaneous tissue

102

2.96

6.96

1.6

6.59

8.50

ug/l

0.55

Other viral diseases, not elsewhere classified

117

685

1.70

6.96

1.5

6.53

6.74

ug/l

0.10

106

613

Personality disorders

121

722

1.68

6.86

1.3

1.5

7.54

6.89

ug/l

0.13

110

647

Disorders of adult personality and behaviour

128

776

1.66

6.84

1.4

1.5

8.24

6.74

ug/l

0.34

116

697

Ischemic heart diseases

274

1156

1.43

6.82

1.5

1.6

8.15

8.21

ug/l

0.02

249

1059

Paroxysmal tachycardia

404

1.85

6.80

1.9

1.6

10.65

7.78

ug/l

0.45

370

Cutaneous abscess, furuncle and carbuncle

103

590

1.75

6.78

1.5

13.61

7.26

ug/l

0.72

537

Disorders of ocular muscles, binocular movement, accommodation and refraction

188

1238

1.51

6.76

1.7

1.5

8.73

7.33

ug/l

0.31

172

1111

Other viral diseases

163

1042

1.56

6.76

1.5

6.56

7.05

ug/l

0.27

147

944

Other bacterial intestinal infections

432

1.88

6.73

1.7

1.6

8.82

8.47

ug/l

0.05

384

Solid cancers, helper endpoint

288

1209

1.41

6.69

1.4

1.5

7.12

7.92

ug/l

0.53

268

1072

Disorders of gallbladder, biliary tract and pancreas

343

1588

1.36

6.65

1.6

1.5

9.19

7.91

ug/l

0.62

308

1436

Misadventures to patients during surgical and medical care

246

2.16

6.48

1.6

1.5

8.99

8.19

ug/l

0.14

214

Cholelithiasis, broad definition with cholecystitis

298

1450

1.38

6.45

1.5

8.71

8.06

ug/l

0.23

268

1309

5-aminosalicylic acid

377

1.92

6.35

1.2

1.6

6.59

8.39

ug/l

0.90

335

Metabolic disorders

334

1502

1.36

6.32

1.4

1.5

8.13

8.19

ug/l

0.02

307

1360

All pneumoniae

376

1891

1.33

6.30

1.8

1.5

11.45

7.36

ug/l

1.60

335

1719

Postmenopausal atrophic vaginitis

291

1.81

6.22

2.0

1.4

10.75

8.05

ug/l

0.49

263

Cholelithiasis

285

1421

1.38

6.20

1.5

8.04

8.11

ug/l

0.02

255

1283

Use of hypnotics and sedatives

378

1633

1.33

6.18

1.5

8.69

7.92

ug/l

0.25

345

1478

Other and unspecified nerve root and plexus disorders, also in other diseases

410

1.86

6.14

1.6

8.05

8.10

ug/l

0.01

369

Diseases of oral cavity, salivary glands and jaws

192

658

1.50

6.12

1.4

1.6

7.71

7.97

ug/l

0.09

164

606

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

128

790

1.61

6.11

1.7

1.4

10.63

6.66

ug/l

0.67

120

699

Myeloid leukaemia

4.15

6.10

3.9

1.2

19.51

6.15

ug/l

1.15

Superficial injury of lower leg

566

1.72

6.03

1.6

9.18

8.23

ug/l

0.13

507

Other diseases of hard tissues of teeth

190

657

1.50

5.98

1.3

1.6

6.90

7.97

ug/l

0.56

164

605

288

2.02

5.98

1.3

1.4

5.05

7.06

ug/l

1.97

256

Biological medication for rheuma

414

1.84

5.97

1.3

1.5

5.92

7.23

ug/l

0.89

365

Secondary hypertension

110

2.71

5.96

1.2

1.7

10.80

9.39

ug/l

0.14

102

Transient ischemic attack

146

761

1.56

5.94

1.3

1.6

12.65

9.23

ug/l

0.54

136

685

Dislocation, sprain and strain of joints and ligaments of knee

234

1533

1.41

5.91

1.4

1.5

6.17

8.07

ug/l

2.34

209

1392

Other and unspecified iron deficiency

108

652

1.66

5.91

1.6

9.43

8.47

ug/l

0.19

101

584

Disorders of breast

195

1219

1.46

5.87

1.5

6.55

7.66

ug/l

0.93

175

1100

Disorders of refraction and accommodation

115

705

1.63

5.86

1.8

1.5

9.87

6.89

ug/l

0.46

106

633

Pneumonias (Asthma/COPD co-morbidities)

370

1888

1.32

5.83

1.7

1.5

11.44

7.37

ug/l

1.55

329

1716

Carcinoma in situ of skin of other and unspecified parts of face

2.83

5.83

1.2

1.3

5.59

9.52

ug/l

1.57

Lichen planus, including avohilmo

361

1.89

5.79

1.4

1.6

6.25

9.07

ug/l

2.03

321

All influenza (not pneumonia)

278

2.02

5.78

1.2

1.6

5.71

8.21

ug/l

1.67

247

Propionic acid derivatives

266

1.78

5.78

1.4

1.6

7.17

8.92

ug/l

0.42

247

Collagenous colitis

174

2.31

5.75

2.4

1.5

13.86

9.14

ug/l

0.39

149

Other diseases of pleura

120

655

1.61

5.72

1.7

1.6

15.11

8.89

ug/l

0.87

111

593

Noninflammatory disorders of female genital tract

175

583

1.51

5.69

1.5

1.4

6.56

6.78

ug/l

0.09

153

520

Other or unspecified immunodeficiency

13.64

5.66

1.2

1.4

5.97

7.86

ug/l

—

Disturbance of activity and attention

329

1.92

5.65

1.6

1.3

5.05

5.72

ug/l

0.53

286

Lesion of ulnar nerve

254

2.06

5.63

1.3

1.7

6.13

9.26

ug/l

1.65

225

Methotrexate

234

2.10

5.62

1.2

1.6

5.91

9.31

ug/l

1.66

207

Injuries to the head

407

1934

1.29

5.60

1.5

8.68

7.81

ug/l

0.37

368

1753

Nontoxic goitre/thyroid nodule

595

1.67

5.56

1.9

1.5

12.20

8.28

ug/l

0.53

530

Otitis externa, unspecified

229

2.11

5.53

1.4

1.5

5.34

8.53

ug/l

1.97

199

Hyperkinetic disorders

352

1.87

5.53

1.7

1.3

5.49

5.63

ug/l

0.07

309

Other abnormal uterine and vaginal bleeding

330

1.78

5.52

1.5

1.4

7.35

7.46

ug/l

0.03

294

Endometriosis of pelvic peritoneum

363

1.84

5.51

1.4

5.93

6.85

ug/l

0.54

323

All kidney diseases

360

1880

1.31

5.51

1.6

1.5

12.47

7.18

ug/l

1.89

325

1701

Hypothyroidism, drug reimbursement

181

2.07

5.50

1.3

1.6

10.69

10.14

ug/l

0.04

163

Benign neoplasm of other and ill-defined parts of digestive system

319

1.92

5.46

1.4

1.6

7.60

9.05

ug/l

0.56

283

Other enthesopathy of foot (+metatarsalgia)

191

2.21

5.46

1.3

1.7

5.57

8.54

ug/l

1.32

168

GI-bleeding

523

1.71

5.43

1.9

1.5

14.67

9.08

ug/l

0.88

474

Hernia

320

1615

1.33

5.42

1.6

1.5

7.11

8.36

ug/l

0.95

298

1464

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

325

1571

1.33

5.38

1.5

8.02

8.07

ug/l

0.02

302

1417

Irregular menses

210

1174

1.42

5.38

1.5

8.59

7.29

ug/l

0.27

187

1046

Nonsuppurative otitis media

105

558

1.63

5.32

1.8

1.4

8.81

6.54

ug/l

0.31

495

Dental pulpitis, including avohilmo

354

1759

1.31

5.32

1.6

1.5

8.40

7.78

ug/l

0.19

320

1586

Benign paroxysmal vertigo

557

1.67

5.31

1.2

1.5

5.81

8.39

ug/l

2.89

495

Persistent mood disorders

394

1.81

5.30

1.1

1.5

6.50

7.49

ug/l

0.40

346

Any death

953

0.58

5.28

1.3

1.6

7.34

9.40

ug/l

1.62

863

Tumor necrosis factor alpha inhibitors

373

1.83

5.28

1.3

1.4

5.69

7.15

ug/l

1.06

329

Disorders of vitreous body and globe

154

996

1.49

5.28

1.5

10.08

9.24

ug/l

0.12

141

907

Other disorders starting during childhood or adolecense, excluding more controls

2.68

5.26

2.6

1.4

17.07

5.06

ug/l

0.52

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

107

664

1.61

5.23

1.4

1.5

8.55

6.99

ug/l

0.29

598

Zoster [herpes zoster]

317

1.90

5.23

2.3

1.5

12.16

7.83

ug/l

0.64

280

Restless leg syndrome

255

2.01

5.21

1.1

1.5

6.29

8.12

ug/l

0.62

222

Dermatophytosis

207

1478

1.40

5.19

1.5

8.03

8.47

ug/l

0.09

188

1338

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

103

565

1.63

5.18

1.8

1.4

8.56

5.68

ug/l

0.40

494

Renal failure

117

658

1.57

5.15

1.4

1.6

13.13

9.27

ug/l

0.57

107

601

Other and unspecified disorders of vitreous body

128

823

1.54

5.14

1.5

1.6

7.62

8.86

ug/l

0.39

118

751

Disorders of vitreous body

151

984

1.48

5.14

1.5

10.17

9.25

ug/l

0.12

138

895

Exclusions for E4_PCOS_CONSORTIUM

290

1358

1.34

5.13

1.6

1.5

9.41

7.40

ug/l

0.63

258

1223

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

103

640

1.61

5.11

1.2

1.6

7.19

8.70

ug/l

0.94

581

Glucagon-like peptide-1 (GLP-1) analogues

103

640

1.61

5.11

1.2

1.6

7.19

8.70

ug/l

0.94

581

Aplastic and other anaemias

123

741

1.55

5.10

1.8

1.5

11.57

8.75

ug/l

0.63

106

680

Otitis externa

488

1.71

5.09

1.4

6.36

7.39

ug/l

0.69

434

Other CVD (FINNGEN)

115

2.37

5.09

1.5

1.7

22.96

8.91

ug/l

0.60

108

Acetic acid derivatives and related substances

233

1.79

5.07

1.4

1.7

5.34

9.42

ug/l

1.50

217

Inflammatory disorders of breast

159

2.28

5.05

1.7

1.5

7.48

7.31

ug/l

0.04

137

Other symptoms and signs involving cognitive functions and awareness

126

748

1.54

5.01

1.5

7.95

8.87

ug/l

0.35

120

672

Artificial joint operation, meniscal resection

281

1364

1.34

5.01

1.3

1.6

8.73

8.56

ug/l

0.04

251

1251

Chronic kidney disease

422

1.75

5.00

1.5

1.6

16.14

9.70

ug/l

0.62

383

Conduction disorders

394

1.71

5.00

1.4

1.5

6.48

8.44

ug/l

0.83

360

Other CVD

259

1.97

4.99

1.6

19.62

9.08

ug/l

0.68

228

Reimbursement for rheumatic diseases

195

1384

1.41

4.99

1.7

1.5

9.71

8.39

ug/l

0.27

175

1262

Infections with a predominantly sexual mode of transmission

130

858

1.52

4.94

1.6

1.4

10.07

6.93

ug/l

0.49

120

770

Other bacterial intestinal infections

303

1.89

4.90

1.8

1.6

10.08

8.76

ug/l

0.16

268

Carcinoma in situ of skin of upper limb, including shoulder

4.61

4.88

1.4

1.2

8.29

6.31

ug/l

0.59

Other and unspecified anaemias

110

669

1.57

4.86

1.7

1.5

9.83

9.03

ug/l

0.21

614

Sequelae of injuries, of poisoning and of other consequences of external causes

518

1.67

4.85

1.6

1.5

8.85

7.46

ug/l

0.21

462

DVT of lower extremities and pulmonary embolism

116

749

1.54

4.81

1.4

1.6

7.14

9.37

ug/l

1.50

106

675

Coxarthrosis

130

563

1.53

4.80

1.3

1.6

7.57

9.48

ug/l

0.89

116

509

Bleeding

253

1337

1.35

4.80

1.6

1.5

12.42

7.98

ug/l

1.31

229

1220

Bacterial intestinal infections, IBD co-morbidities

327

1.84

4.78

1.7

1.5

9.74

8.12

ug/l

0.22

288

Iron deficiency anaemia

129

846

1.51

4.74

1.6

1.5

9.63

8.21

ug/l

0.36

120

765

Other anaemias

111

679

1.56

4.74

1.7

1.5

9.76

8.98

ug/l

0.21

623

Paracetamol or NSAID medication

140

1.98

4.73

1.4

5.99

7.20

ug/l

0.30

129

Inflammatory bowel disease

116

757

1.54

4.70

1.6

1.4

7.34

7.36

ug/l

0.00

104

682

Specific personality disorders

608

1.60

4.68

1.4

9.09

6.60

ug/l

0.47

540

Hypo-osmolality and hyponatraemia

264

1.93

4.68

1.1

1.5

7.71

9.04

ug/l

0.27

236

Acute suppurative otitis media

116

706

1.54

4.67

1.6

1.4

9.07

6.24

ug/l

0.46

105

637

Other extrapyramidal and movement disorders in other diseases

441

1.71

4.64

1.1

1.6

6.16

8.89

ug/l

1.54

393

Bruxism

3.54

4.63

1.3

1.6

4.85

6.79

ug/l

1.01

Thyroiditis, ILD-related definition

253

1.95

4.62

1.3

1.4

5.53

6.78

ug/l

0.81

223

Fall on same level involving ice and snow

192

1387

1.39

4.59

1.5

7.12

8.35

ug/l

0.44

176

1258

Ulcerative proctitis

128

2.36

4.57

1.1

1.4

4.71

8.30

ug/l

1.59

109

Missing teeth due to accident, extraction or parodontitis

176

1181

1.41

4.53

1.4

1.6

10.94

8.95

ug/l

0.32

155

1079

Benign neoplasm: Skin of upper limb, including shoulder

4.23

4.53

1.0

1.4

6.81

6.61

ug/l

0.06

Diseases of middle ear and mastoid

218

1312

1.36

4.53

1.3

1.5

6.17

7.10

ug/l

0.85

193

1192

Other disorders of veins

133

896

1.48

4.52

1.4

1.5

8.03

8.38

ug/l

0.11

120

808

Gonarthrosis,primary

263

1220

1.33

4.48

1.3

1.6

7.84

9.04

ug/l

0.66

232

1117

Pneumonia, organism unspecified

313

1698

1.29

4.47

1.6

1.5

10.03

7.61

ug/l

0.74

279

1547

Mixed and other personality disorders

188

2.09

4.45

1.5

1.4

5.32

7.75

ug/l

1.37

162

Acne

278

1.88

4.42

1.3

5.08

5.60

ug/l

0.32

245

Polycystic ovarian syndrome, consortium definition

289

1309

1.31

4.41

1.5

7.98

7.45

ug/l

0.14

263

1175

Nutritional anaemias

145

967

1.45

4.41

1.6

1.5

9.15

8.20

ug/l

0.25

136

876

Other menopausal disorders

344

1.61

4.41

1.2

1.4

5.65

7.52

ug/l

1.59

309

Open wound of lower leg

300

1.84

4.41

1.5

7.71

8.13

ug/l

0.09

259

Benign neoplasm: Skin of lower limb, including hip

3.13

4.37

1.8

1.3

9.30

5.97

ug/l

0.52

Panniculitis affecting regions of neck and back

3.11

4.36

1.9

1.7

7.02

8.71

ug/l

0.26

Mouth breathing

133

907

1.47

4.36

1.4

1.6

7.15

8.56

ug/l

0.96

116

824

Hernia of abdominal wall

138

950

1.46

4.34

1.6

7.05

8.69

ug/l

0.75

126

861

Infections with a predominantly sexual mode of transmission

168

1115

1.41

4.34

1.6

1.4

9.73

6.62

ug/l

0.63

150

1004

Unknown and unspecified causes of morbidity

101

2.49

4.29

1.4

1.6

6.05

7.24

ug/l

0.35

Extrapyramidal and movement disorders

107

702

1.53

4.27

1.2

1.5

6.23

8.72

ug/l

2.08

637

Chronic apical periodontitis

400

1823

1.25

4.23

1.7

1.4

11.00

7.38

ug/l

1.52

361

1654

Other disorders of eyelid

118

754

1.49

4.20

1.6

10.10

8.70

ug/l

0.32

105

695

Glaucoma suspect

100

649

1.54

4.20

1.2

1.6

6.88

9.37

ug/l

1.48

584

Disorders of sclera, cornea, iris and ciliary body

180

1308

1.38

4.19

1.5

6.76

8.56

ug/l

1.24

161

1181

Other specified/unspecified soft tissue disorders

2.76

4.18

1.3

1.5

4.79

8.49

ug/l

1.42

Ménière disease

166

2.12

4.18

1.2

1.5

5.89

8.84

ug/l

1.60

143

Appendectomy

237

1719

1.32

4.14

1.7

1.5

9.87

7.70

ug/l

0.43

212

1550

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

347

1876

1.26

4.11

1.8

1.5

11.14

7.41

ug/l

1.35

308

1706

Adalimumab

222

1.95

4.10

1.1

1.5

5.12

7.26

ug/l

1.33

195

Major coronary heart disease event excluding revascularizations

156

733

1.42

4.08

1.4

1.7

12.34

8.91

ug/l

0.60

139

667

Injuries to the shoulder and upper arm

271

1686

1.30

4.07

1.5

9.23

8.08

ug/l

0.38

244

1535

Tinnitus

445

1.64

4.00

1.4

1.6

7.81

8.25

ug/l

0.14

395

Gonarthrosis, primary, with knee surgery

153

864

1.41

4.00

1.3

1.6

8.24

9.38

ug/l

0.42

135

791

IBD patients in KELA-register

547

1.58

3.97

1.4

1.5

7.75

7.28

ug/l

0.10

486

Dental operations

191

715

1.37

3.95

1.4

1.5

8.60

7.54

ug/l

0.42

167

662

Erythema intertrigo

4.49

3.94

1.1

4.98

6.00

ug/l

0.50

Foreign body in respiratory tract

100

2.42

3.89

1.6

5.77

6.49

ug/l

0.20

Persons encountering health services for specific procedures, not carried out

178

2.03

3.88

1.4

13.07

7.70

ug/l

0.34

146

Acute appendicitis, no complications

201

1499

1.34

3.88

1.8

1.4

10.58

7.35

ug/l

0.60

181

1355

Hallux valgus (acquired)

448

1.54

3.86

1.8

1.5

10.85

9.10

ug/l

0.27

402

Excessive vomiting in pregnancy

213

1.94

3.86

1.3

1.4

6.48

5.70

ug/l

0.22

182

Phobic anxiety disorders

328

1.74

3.86

1.8

1.5

8.58

6.43

ug/l

0.57

290

Premenstrual syndrome

4.37

3.84

1.2

1.5

6.18

5.47

ug/l

0.20

Other predominantly sexually transmitted diseases, not elsewhere classified

577

1.55

3.80

2.0

1.4

13.42

6.41

ug/l

0.88

517

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

2.49

3.80

1.0

1.6

5.51

7.58

ug/l

0.66

Hypokalaemia

201

1.95

3.76

1.3

1.5

8.05

7.71

ug/l

0.10

176

Superficial injury of abdomen, lower back and pelvis

332

1.72

3.73

1.1

1.4

5.24

7.26

ug/l

1.76

290

Diseases of pulp and periapical tissues, including avohilmo

371

1547

1.24

3.72

1.5

7.18

7.50

ug/l

0.16

341

1400

Appendicitis, broad definition

257

1810

1.29

3.72

1.8

1.5

10.73

7.51

ug/l

0.73

228

1639

Umbilical hernia

533

1.56

3.70

1.5

6.20

8.99

ug/l

1.86

477

Heart failure and antihypertensive medication

272

1.66

3.70

1.8

1.6

13.05

9.05

ug/l

0.31

251

Diseases of appendix

258

1818

1.28

3.63

1.8

1.5

10.70

7.51

ug/l

0.73

229

1645

Melanocytic naevi of scalp and neck

2.97

3.58

1.2

1.4

5.89

6.40

ug/l

0.18

Other septicaemia

624

1.50

3.58

2.1

1.5

15.75

7.90

ug/l

1.70

566

Angina pectoris

147

702

1.40

3.57

1.7

1.6

13.74

8.76

ug/l

0.85

131

639

Atrophic disorders of skin

277

1.77

3.57

1.7

1.6

7.61

8.28

ug/l

0.12

239

Diseases of liver

103

700

1.47

3.55

1.5

11.40

8.36

ug/l

0.38

629

Problems related to social environment

3.07

3.53

1.3

5.78

5.98

ug/l

0.07

Spondyloarthritis

353

1.68

3.52

1.4

1.5

5.48

7.99

ug/l

2.82

314

Seropositive rheumatoid arthritis

445

1.59

3.48

1.6

1.5

8.56

8.46

ug/l

0.01

403

Anti-inflammatory and antirheumatic products, non-steroids

266

1.57

3.40

1.3

1.6

6.93

8.92

ug/l

0.48

247

Acute appendicitis

240

1757

1.28

3.37

1.9

1.5

10.89

7.54

ug/l

0.71

213

1591

Disorders of mineral metabolism

140

2.08

3.37

1.1

1.5

6.05

8.12

ug/l

0.84

123

Inflammatory bowel disease, strict (require KELA)

571

1.51

3.34

1.4

1.5

7.75

7.07

ug/l

0.15

511

Gingivitis and periodontal diseases

343

1433

1.24

3.32

1.5

7.95

7.37

ug/l

0.27

308

1300

Benign neoplasm: Rectum, anus and anal canal

344

1.66

3.31

1.7

1.5

11.10

8.62

ug/l

0.33

306

Other facial nerve disorders

2.94

3.30

1.1

1.7

6.11

8.45

ug/l

0.39

Adenomyosis (Endometriosis of uterus)

233

1.81

3.28

1.9

1.5

8.98

7.75

ug/l

0.25

208

Paralytic ileus and intestinal obstruction

407

1.60

3.26

1.5

1.7

7.24

9.86

ug/l

0.57

376

Benign lipomatous neoplasm

601

1.48

3.20

1.6

1.5

7.22

8.35

ug/l

0.61

538

Squamous cell neoplasms and carcinomas of the skin

2.51

3.20

1.2

1.4

6.63

9.97

ug/l

0.77

Acute pancreatitis

340

1.65

3.20

1.4

1.5

8.17

7.89

ug/l

0.08

301

Superficial injury of thorax

287

1.71

3.19

1.4

1.5

11.98

8.24

ug/l

0.38

251

Complications of internal orthopaedic prosthetic devices, implants and grafts

340

1.65

3.19

1.5

6.84

9.14

ug/l

0.81

308

Diseases of arteries, arterioles and capillaries

172

955

1.33

3.19

1.4

1.5

11.95

8.47

ug/l

0.75

163

858

Use of pramipexole

402

1.60

3.19

1.7

9.88

9.38

ug/l

0.06

359

Disorders of lens

190

901

1.32

3.19

1.5

1.6

11.15

8.44

ug/l

0.62

172

820

Presence of other functional implants

151

771

1.36

3.19

1.5

1.6

11.80

8.85

ug/l

0.50

130

702

Suppurative and unspecified otitis media

140

908

1.37

3.18

1.5

8.32

6.76

ug/l

0.26

125

822

Benign neoplasm: Rectum

295

1.70

3.18

1.8

1.5

11.90

8.78

ug/l

0.37

261

Endometriosis ASRM stages 1,2

468

1.54

3.12

1.5

6.08

7.11

ug/l

0.58

416

Other disorders starting during childhood or adolescence

130

2.07

3.10

2.6

1.4

17.07

5.06

ug/l

0.52

116

Type1 diabetes, definitions combined, early onset

183

0.27

3.09

1.2

1.5

48.10

6.50

ug/l

—

160

Sequelae of other and unspecified effects of external causes

7.68

3.07

3.0

1.3

8.30

6.84

ug/l

—

Alzheimer disease, including avohilmo

341

0.49

3.04

1.7

1.5

8.79

9.79

ug/l

0.22

305

Coxarthrosis [arthrosis of hip](FG)

138

711

1.37

3.04

1.3

1.6

7.63

9.36

ug/l

0.90

124

648

Stomatitis and related lesions

463

1.54

3.03

1.6

1.5

7.62

7.44

ug/l

0.05

409

Other specified/unspecified systemic involvement of connective tissue

106

2.18

3.03

1.1

1.6

9.44

8.12

ug/l

0.13

Car occupant injured in other and unspecified transport accidents

464

1.53

3.01

1.3

1.5

9.26

7.25

ug/l

0.25

408

Crohn disease

300

1.67

3.01

1.7

1.4

7.88

7.67

ug/l

0.03

261

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

179

1193

1.31

3.00

1.5

1.4

8.07

6.96

ug/l

0.34

160

1071

Hypotension

218

1.79

3.00

1.4

1.6

22.86

9.27

ug/l

0.68

191

STROKE

164

840

1.33

2.99

1.4

1.6

11.07

8.66

ug/l

0.40

153

766

Lactose intolerance

2.48

2.96

1.5

1.6

6.81

7.07

ug/l

0.05

Pregnancy hypertension

164

1116

1.32

2.95

1.5

1.4

8.04

7.06

ug/l

0.26

149

995

Haemangioma, any site

169

1.90

2.94

1.5

1.6

6.25

8.09

ug/l

0.74

146

Dental caries, including avohilmo

233

938

1.27

2.93

1.6

1.5

8.17

7.63

ug/l

0.22

204

857

Endometriosis of ovary

355

1.60

2.93

1.5

1.4

8.06

7.38

ug/l

0.15

315

Rheumatoid arthritis, including avohilmo

110

788

1.40

2.92

1.5

8.21

8.13

ug/l

0.02

101

709

Benign neoplasm: Skin of scalp and neck

2.85

2.92

1.2

4.78

5.67

ug/l

0.39

Acute pancreatitis (for exclusion)

349

1.61

2.92

1.4

1.5

8.17

8.41

ug/l

0.06

306

Glaucoma

142

910

1.34

2.91

1.4

1.5

9.01

9.09

ug/l

0.02

128

835

Other acute skin changes due to ultraviolet radiation

2.71

2.89

1.1

1.5

6.12

7.02

ug/l

0.26

Other and unspecified abdominal hernia

2.52

2.87

1.6

1.3

7.24

9.30

ug/l

0.38

Sulfasalazine

518

1.49

2.86

1.5

1.6

9.25

8.04

ug/l

0.18

465

Psoriatic arthropathies

178

1.86

2.86

1.2

1.5

7.68

7.88

ug/l

0.05

155

Other respiratory diseases principally affecting the interstitium

259

1.70

2.85

1.6

1.5

9.65

8.79

ug/l

0.14

228

Explicit Sepsis

114

771

1.38

2.82

2.0

1.5

14.55

7.82

ug/l

1.66

107

692

Myocardial infarction, without ST-elevation

517

1.46

2.82

1.1

1.6

13.05

9.27

ug/l

0.36

476

Haemangioma and lymphangioma, any site

179

1.85

2.81

1.5

1.6

6.16

9.08

ug/l

1.25

155

Lactose intolerance, other/unspecified

2.56

2.79

1.5

1.7

7.11

7.55

ug/l

0.07

Covid-19 suspected case

546

1.47

2.79

1.4

1.5

5.67

7.06

ug/l

1.03

482

Fall on and from stairs and steps

546

1.47

2.78

1.2

1.5

6.24

8.26

ug/l

1.09

483

Use of donepezil

212

0.36

2.78

1.3

1.5

7.43

10.65

ug/l

—

190

Immunodeficiency associated with other major defects

8.69

2.78

10.6

1.2

78.22

6.20

ug/l

—

Ventral hernia

449

1.52

2.78

1.6

7.56

9.28

ug/l

0.36

402

Renal tubulo-interstitial diseases

283

1720

1.23

2.77

1.6

1.5

13.77

7.49

ug/l

1.76

250

1565

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

135

1.97

2.77

2.6

1.4

17.07

5.23

ug/l

0.51

117

Septicaemia

105

706

1.39

2.73

2.1

1.5

15.41

7.78

ug/l

1.82

639

Caries of dentine, including avohilmo

253

1038

1.25

2.72

1.5

7.93

7.42

ug/l

0.23

220

946

Psoriatic and enteropathic arthropathies

218

1.75

2.71

1.1

1.7

7.28

9.65

ug/l

0.72

196

Common variable immunodeficiency

6.13

2.71

1.3

1.4

6.42

7.24

ug/l

—

Acute and subacute iridocyclitis

381

1.55

2.68

1.4

7.96

8.02

ug/l

0.02

340

Haemorrhage in early pregnancy

113

807

1.37

2.64

1.2

1.4

5.00

7.06

ug/l

2.55

718

Injuries to the hip and thigh

126

851

1.34

2.62

1.8

1.5

13.59

8.05

ug/l

0.83

117

766

Idiopathic gout

113

2.04

2.61

1.5

1.7

10.00

9.99

ug/l

0.00

101

Bacterial pneumonia (organism specified)

115

768

1.36

2.59

2.0

1.4

15.95

7.89

ug/l

1.18

104

697

Other disorders of ear

283

1522

1.22

2.58

1.5

8.85

8.27

ug/l

0.17

264

1375

Disorders of lipoprotein metabolism and other lipidaemias

233

1161

1.24

2.57

1.5

1.6

7.94

8.96

ug/l

0.41

219

1053

Adult-onset Still disease

7.33

2.56

1.8

1.3

3.28

8.23

ug/l

—

Pacemaker

407

1.51

2.56

1.5

1.6

8.76

9.75

ug/l

0.21

372

Chronic nephritic syndrome

2.43

2.54

1.6

1.2

9.97

6.15

ug/l

0.97

Type 1 diabetes, strict definition, subgroup 1

210

0.38

2.53

1.1

1.5

35.78

6.43

ug/l

—

185

Hypertrophy of breast in women and men

494

1.46

2.48

1.4

6.76

7.71

ug/l

0.40

442

Superficial injury of shoulder and upper arm

232

1.69

2.48

1.3

1.4

14.47

8.16

ug/l

0.46

201

Ischaemic heart disease, wide definition

208

1028

1.25

2.48

1.5

1.6

10.82

8.70

ug/l

0.47

184

942

COPD

544

1.40

2.48

1.6

15.60

9.27

ug/l

0.69

491

Ulcerative colitis

552

1.43

2.48

1.4

1.5

6.48

7.85

ug/l

0.75

491

Iridocyclitis

462

1.47

2.46

1.4

7.52

7.79

ug/l

0.09

412

Bacterial pneumonia, not elsewhere classified

102

655

1.37

2.46

2.1

1.4

13.35

7.98

ug/l

1.04

598

Non-rheumatic valve diseases

117

628

1.35

2.42

1.8

1.5

9.09

8.37

ug/l

0.22

106

575

Type 1 diabetes, strict definition

222

0.40

2.42

1.1

1.6

32.51

6.87

ug/l

—

196

Polycythaemia vera

2.91

2.41

2.0

1.4

13.60

11.27

ug/l

0.12

Diseases of male genital organs

129

487

1.34

2.41

1.6

8.27

7.79

ug/l

0.15

119

446

Chondromalacia

2.43

2.37

1.0

1.6

5.24

6.15

ug/l

0.49

Other chronic obstructive pulmonary disease

512

1.40

2.37

1.4

1.6

10.15

9.43

ug/l

0.12

465

Non-invasive ventilation

409

1.46

2.33

1.4

1.6

10.66

7.26

ug/l

0.84

376

Diseases of pulp and periapical tissues and dental caries

204

836

1.25

2.33

1.6

1.4

8.53

7.37

ug/l

0.51

176

766

Benign neoplasm of mouth and pharynx

199

1.71

2.31

1.2

1.5

6.37

8.78

ug/l

1.07

171

Senile cataract

162

776

1.28

2.31

1.3

1.6

11.34

8.70

ug/l

0.49

145

705

Pedestrian injured in transport accident

119

1.94

2.30

1.3

1.6

4.99

9.77

ug/l

1.96

102

Personal history of other diseases and conditions

291

1.58

2.29

1.5

5.68

6.11

ug/l

0.18

257

Valvular heart disease excluding rheumatic fever

117

635

1.33

2.28

1.8

1.5

9.09

8.38

ug/l

0.22

106

582

Varicella [chickenpox]

2.23

2.27

3.3

1.6

25.04

7.86

ug/l

0.41

Psoriasis

596

1.39

2.26

1.3

1.5

7.43

7.81

ug/l

0.11

538

Anterior Iridocyclitis

406

1.48

2.25

1.4

7.89

7.85

ug/l

0.01

360

Intestinal stricture

538

1.41

2.25

1.4

1.7

7.15

9.21

ug/l

0.50

488

Hypoparathyroidism

2.29

2.25

2.8

1.8

18.51

9.53

ug/l

0.38

Pleural plaque with presence of asbestos

2.16

2.24

1.1

1.3

7.12

9.15

ug/l

0.54

Other and unspecified mood [affective] disorders

171

1.76

2.24

1.3

1.5

4.78

6.79

ug/l

1.25

146

All chronic kidney diseases

146

931

1.28

2.23

1.3

1.5

11.36

8.02

ug/l

0.64

134

838

Systemic disorders of connective tissue in diseases classified elsewhere

5.71

2.23

1.0

1.4

5.84

8.73

ug/l

—

Vasomotor rhinitis (mode)

142

1.84

2.23

1.6

11.28

8.33

ug/l

0.34

123

Bipolar affective disorders

440

1.46

2.22

1.2

1.5

5.00

7.06

ug/l

2.25

389

Alzheimer disease

278

0.53

2.20

1.5

1.4

8.58

10.23

ug/l

0.38

247

Pre-eclampsia or eclampsia

583

1.39

2.19

1.3

1.4

6.53

6.48

ug/l

0.02

525

Early onset COPD

392

1.48

2.19

1.6

10.17

9.39

ug/l

0.11

354

Other and unspecified mononeuropathies of lower limb

2.52

2.19

1.1

1.6

5.95

8.58

ug/l

0.58

Hypertrophy of breast

450

1.45

2.18

1.4

1.5

6.71

7.33

ug/l

0.22

403

Statin medication

236

1090

1.22

2.17

1.3

1.6

7.66

8.05

ug/l

0.12

210

983

Postmenopausal bleeding

275

1.44

2.17

1.6

1.5

7.93

8.16

ug/l

0.07

252

Pre-eclampsia

543

1.40

2.15

1.3

1.4

6.61

6.47

ug/l

0.06

488

Acute tubulo-interstitial nephritis

188

1312

1.24

2.14

1.7

1.5

13.12

7.59

ug/l

1.07

163

1194

Bacterial pneumoniae

106

703

1.33

2.14

2.1

1.4

16.96

7.93

ug/l

1.25

642

Intestinal malabsorption

2.06

2.11

1.9

1.7

10.07

7.29

ug/l

0.71

Fissure and fistula of anal and rectal regions

470

1.43

2.11

1.4

1.6

5.94

9.17

ug/l

2.45

426

Blepharochalasis

512

1.41

2.10

1.8

1.6

12.80

9.03

ug/l

0.61

464

Excessive attrition of teeth

190

1548

1.23

2.08

1.4

1.5

7.07

7.60

ug/l

0.27

174

1397

Conductive and sensorineural hearing loss

216

1197

1.22

2.07

1.6

1.5

9.72

8.89

ug/l

0.19

203

1081

Epilepsy

588

1.38

2.06

1.3

1.6

6.09

8.06

ug/l

1.48

532

Pure hypercholesterolaemia

197

1046

1.23

2.06

1.5

1.6

8.51

9.34

ug/l

0.26

185

947

Ascites

2.03

2.05

1.2

1.4

6.26

8.17

ug/l

0.50

Effects of foreign body entering through natural orifice

540

1.39

2.05

1.4

1.5

10.49

7.52

ug/l

0.25

480

Other cataract

110

633

1.32

2.04

1.6

11.92

8.84

ug/l

0.39

102

572

Molar incisor enamel hypoplasia, with caries

4.03

2.03

2.3

2.1

8.43

6.07

ug/l

—

Open wound of abdomen, lower back and pelvis

2.41

2.03

1.3

1.5

5.73

8.61

ug/l

0.52

Contact with sharp object, undetermined intent

2.52

2.01

2.1

1.4

7.28

6.85

ug/l

0.06

Torsion of ovary, ovarian pedicle and fallopian tube

2.52

2.01

2.5

1.5

8.58

7.72

ug/l

0.07

Fracture at wrist and hand level

105

799

1.31

1.99

1.5

6.37

7.63

ug/l

0.91

710

Superficial injury of head

484

1.41

1.99

1.9

1.6

9.66

7.97

ug/l

0.20

431

Other metabolic disorders

296

1.52

1.97

1.6

1.5

12.00

7.45

ug/l

0.40

257

Gestational [pregnancy-induced] hypertension

100

758

1.32

1.95

1.4

6.17

6.99

ug/l

0.37

683

Sensorineural hearing loss

197

1097

1.22

1.93

1.5

1.6

8.29

9.13

ug/l

0.33

185

991

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

107

823

1.30

1.92

1.4

8.55

6.73

ug/l

0.35

741

Thyrotoxicosis, other and/or unspecified

438

1.42

1.91

1.8

1.6

16.06

8.43

ug/l

0.56

392

Open wound of wrist and hand

137

1063

1.26

1.91

1.7

1.5

8.24

7.60

ug/l

0.14

124

954

Keratitis

106

815

1.30

1.91

1.5

6.29

7.66

ug/l

0.63

738

Hydrocele

150

1.74

1.90

2.0

1.4

17.62

8.48

ug/l

0.55

140

Seropositive rheumatoid arthritis, wide

515

1.38

1.88

1.6

1.5

8.56

8.25

ug/l

0.04

459

Labour and delivery complicated by umbilical cord complications

121

1.83

1.88

1.1

1.5

3.62

6.50

ug/l

2.22

104

Injury of muscle and tendon at shoulder and upper arm level

688

1.32

1.85

1.5

6.91

8.73

ug/l

1.06

622

Schizophrenia or delusion

754

0.70

1.83

1.6

1.5

6.48

7.45

ug/l

0.45

678

Female genital prolapse

346

1.36

1.83

1.6

1.4

9.25

7.56

ug/l

0.26

309

Abrasion of teeth

103

795

1.30

1.82

1.3

1.5

5.10

8.22

ug/l

4.11

717

Other and unspecified mononeuropathies of upper limb

2.28

1.81

1.5

1.4

4.63

5.82

ug/l

0.56

Other female pelvic inflammatory diseases

344

1.46

1.79

1.1

1.5

5.58

8.00

ug/l

1.66

305

Primary coxarthrosis, bilateral

444

1.40

1.79

1.4

1.6

6.53

9.57

ug/l

2.14

400

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

279

1.51

1.78

1.5

7.49

8.41

ug/l

0.28

243

Pleural plaque

102

1.87

1.76

1.2

8.17

8.96

ug/l

0.15

Atrial fibrillation and flutter

413

1.34

1.75

1.9

1.7

10.40

8.30

ug/l

0.48

375

Cystic kidney disease

2.23

1.74

1.0

1.4

6.97

8.18

ug/l

0.23

Chronic periodontitis, including avohilmo

293

1688

1.16

1.74

1.6

1.5

10.19

7.89

ug/l

0.69

258

1538

Thyrotoxicosis

575

1.34

1.73

1.7

1.5

14.89

8.13

ug/l

0.64

515

Retention of urine

463

1.35

1.73

1.4

7.27

9.43

ug/l

0.88

414

Need for other prophylactic measures

110

1.83

1.73

1.5

1.7

7.47

10.31

ug/l

0.36

Pre-eclampsia or poor fetal growth

117

922

1.27

1.73

1.4

6.60

7.12

ug/l

0.25

104

823

Right ventricular outflow tract obstruction

3.89

1.72

1.4

1.8

4.24

5.29

ug/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

372

1.43

1.72

1.4

1.5

6.28

7.79

ug/l

0.95

328

Schizophrenia, schizotypal and delusional disorders

755

0.71

1.71

1.6

1.5

6.45

7.45

ug/l

0.48

679

Focal epilepsy, strict definition

390

1.41

1.69

1.4

5.90

7.64

ug/l

1.25

344

Arthropod-borne viral fevers and viral haemorrhagic fevers

365

1.43

1.69

1.4

1.5

5.42

7.99

ug/l

2.46

323

Other/unspecified seropositive rheumatoid arthritis

509

1.36

1.68

1.6

1.5

8.62

8.29

ug/l

0.05

454

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

501

1.36

1.67

1.6

1.5

8.73

8.31

ug/l

0.06

448

Other obstetric conditions, not elsewhere classified

141

723

1.24

1.67

1.1

1.5

4.82

6.37

ug/l

1.87

120

649

Primary gonarthrosis, bilateral

120

817

1.26

1.67

1.3

1.7

7.05

9.91

ug/l

1.72

108

746

Cytomegaloviral disease

2.52

1.67

2.3

1.3

10.70

6.69

ug/l

—

Testicular dysfunction

2.11

1.65

3.0

1.4

11.45

7.89

ug/l

0.48

Periodontitis

293

1692

1.16

1.65

1.6

1.5

10.19

7.90

ug/l

0.69

258

1541

Cytomegalovirus infection, IBD co-morbidity

2.46

1.64

2.3

1.2

10.70

5.98

ug/l

—

Rare circulating lymphoid malignancy, including Hilmo

2.45

1.64

1.0

1.5

6.42

8.57

ug/l

—

COPD, hospital admission 2, with asthma infections

416

1.36

1.62

1.2

1.6

9.44

9.48

ug/l

0.01

381

Disorder of the sleep-wake schedule

2.40

1.62

1.4

1.5

4.33

5.92

ug/l

—

Disorders of eyelid in diseases classified elsewhere

2.15

1.61

1.4

1.5

5.41

7.55

ug/l

0.46

Diffuse large B-cell lymphoma, including Hilmo

2.15

1.61

1.0

1.4

6.13

8.05

ug/l

0.47

Diffuse large B-cell lymphoma, helper endpoint

2.15

1.61

1.0

1.4

6.13

8.05

ug/l

0.47

Diffuse large B-cell lymphoma

2.15

1.61

1.0

1.4

6.13

8.05

ug/l

0.47

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

137

703

1.24

1.60

1.2

1.4

4.83

6.23

ug/l

1.58

118

630

Post-traumatic wound infection, not elsewhere classified

2.34

1.59

1.0

1.3

29.02

5.91

ug/l

—

Heart failure,strict

115

645

1.26

1.58

1.5

10.94

8.79

ug/l

0.26

103

588

Presence of cardiac and vascular implants and grafts

542

1.29

1.58

1.4

1.6

12.98

9.17

ug/l

0.43

496

Burns and corrosions

304

1.45

1.58

2.1

1.5

8.67

7.94

ug/l

0.11

268

Other hearing loss

379

1.40

1.57

1.4

1.7

8.33

10.27

ug/l

0.47

338

Endometriosis ASRM stages 3,4

559

1.33

1.57

1.4

1.5

7.38

6.81

ug/l

0.17

496

Focal epilepsy

430

1.37

1.57

1.4

1.5

5.97

7.64

ug/l

1.30

381

Small fibre neuropathy

2.28

1.56

1.2

5.51

5.79

ug/l

—

Varicella [chickenpox]

1.85

1.55

3.2

1.5

23.83

7.15

ug/l

0.43

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

1.89

1.55

2.3

1.7

18.54

8.91

ug/l

0.45

Malignant neoplasm of respiratory system and intrathoracic organs

206

0.52

1.54

2.3

1.6

10.20

9.00

ug/l

0.19

182

Other bursitis of hip

2.44

1.54

1.5

1.8

5.79

10.35

ug/l

—

Kela-code for severe mental illness

888

0.75

1.53

1.5

6.16

7.29

ug/l

0.66

805

Endometriosis diagnosis and infertility diagnosis occurring together

273

1.47

1.53

1.2

1.4

5.37

6.24

ug/l

0.43

241

Malignant neoplasm of bronchus and lung

183

0.50

1.53

1.5

1.6

8.44

9.44

ug/l

0.15

161

Unspecified haematuria

631

1.28

1.52

1.6

9.10

9.57

ug/l

0.08

568

Other noninflammatory disorders of uterus, except cervix

266

1.39

1.52

1.8

1.5

9.44

8.13

ug/l

0.21

240

Localized scleroderma [morphea]

2.61

1.52

1.0

1.1

6.81

5.91

ug/l

—

Necrosis of pulp, including avohilmo

187

1574

1.19

1.51

1.6

1.5

8.24

7.69

ug/l

0.22

175

1416

Other psoriatic arthropathies

217

1.52

1.51

1.2

1.4

7.68

8.47

ug/l

0.20

191

Female infertility, cervical, vaginal, other or unspecified origin

488

1.28

1.51

1.3

5.50

6.56

ug/l

0.95

433

Hyperaldosteronism

2.17

1.51

2.3

1.5

9.52

6.36

ug/l

0.48

Anomalies of dental arch relationship, including avohilmo

492

1.32

1.49

1.2

1.5

4.52

6.76

ug/l

3.71

437

!Aliquae complicationes praecoces traumatis

1.95

1.49

1.0

1.2

22.31

8.14

ug/l

0.43

Early complications of trauma

1.95

1.49

1.0

1.2

22.31

8.14

ug/l

0.43

Use of antiglaucoma preparations and miotics

101

1.79

1.48

2.2

1.4

15.50

10.52

ug/l

0.24

Calcific aortic valvular stenosis, diagnosis (helper)

339

1.40

1.48

1.5

9.24

9.54

ug/l

0.05

308

Operations 2 for CAVS

339

1.40

1.48

1.5

9.24

9.54

ug/l

0.05

308

Other/unspecified cytomegaloviral diseases

2.45

1.48

2.4

1.3

11.17

6.77

ug/l

—

Fracture of lower leg, including ankle

157

1294

1.20

1.48

1.1

1.6

8.02

8.74

ug/l

0.16

137

1183

Calcific aortic valvular stenosis, including rheumatic fever

339

1.40

1.47

1.5

9.24

9.54

ug/l

0.05

308

Calcific aortic valvular stenosis, operated

340

1.40

1.46

1.5

9.24

9.53

ug/l

0.05

309

Calcific aortic valvular stenosis

340

1.40

1.46

1.5

1.6

9.24

9.53

ug/l

0.05

309

Biomechanical lesions, not elsewhere classified

1.85

1.46

1.3

1.6

8.81

7.92

ug/l

0.10

Postpartum haemorrhage due to anatomy

293

1.44

1.45

1.1

1.4

4.24

6.31

ug/l

2.45

261

Other and unspecified acute skin changes due to ultraviolet radiation

2.51

1.45

1.1

1.3

6.31

6.38

ug/l

—

Atrial fibrillation and flutter with reimbursement

297

1.35

1.44

1.8

1.7

9.81

8.57

ug/l

0.21

275

Systemic sclerosis (FG)

2.32

1.43

1.0

2.0

6.50

10.27

ug/l

—

Type 2 diabetes, definitions combined, including avohilmo

298

1519

1.14

1.41

1.4

1.5

8.65

7.70

ug/l

0.45

266

1374

Injuries to the elbow and forearm

222

1680

1.16

1.41

1.6

1.5

9.59

8.05

ug/l

0.41

202

1524

Other abnormal products of conception

134

728

1.22

1.40

1.4

5.74

7.37

ug/l

0.99

117

651

Other and unspecified disorders of psychological development

2.69

1.40

1.8

2.0

4.32

6.06

ug/l

—

Autonomic disorders

2.26

1.40

1.6

1.5

4.17

6.18

ug/l

—

Cerebral aneurysm, nonruptured

165

1.58

1.40

2.0

1.5

9.88

8.58

ug/l

0.17

141

Respiratory insufficiency

1.85

1.38

1.2

1.4

13.15

8.14

ug/l

0.38

Nephrotic syndrome

2.09

1.38

1.5

12.01

6.25

ug/l

0.58

Occupational exposure to risk-factors

2.01

1.38

1.3

1.4

5.83

8.48

ug/l

0.65

Unspecified mental disorder

1029

0.79

1.38

1.4

1.5

6.82

7.16

ug/l

0.13

933

Cardiomyopathy, other and unspecified

119

1.68

1.37

1.2

1.4

6.71

6.90

ug/l

0.03

107

Ulcerative colitis (strict definition, all Crohn cases excluded)

322

1.40

1.37

1.1

1.4

6.96

7.45

ug/l

0.14

282

Type 2 diabetes, wide definition

213

1169

1.17

1.37

1.5

1.6

10.89

8.47

ug/l

0.54

195

1063

Urethritis and urethral syndrome

2.21

1.37

2.1

1.2

6.76

5.99

ug/l

—

Granuloma annulare

2.63

1.37

1.8

1.2

6.42

5.95

ug/l

—

Female infertility

104

505

1.25

1.37

1.2

1.3

5.37

6.59

ug/l

1.31

450

Myocardial infarction

105

594

1.24

1.35

1.2

1.6

11.82

8.63

ug/l

0.38

542

Otitis media, unspecified

274

1.41

1.34

1.4

1.5

5.08

6.18

ug/l

0.63

242

Neuromuscular dysfunction of bladder

159

1.58

1.34

1.1

1.5

23.88

9.00

ug/l

0.36

136

Foreign body or object entering through skin

120

1.67

1.34

1.9

1.4

10.00

7.94

ug/l

0.28

103

Alzheimer’s disease (Late onset)

187

0.54

1.33

1.8

1.5

9.28

10.55

ug/l

0.21

166

Postprocedural endocrine and metabolic disorders, not elsewhere classified

282

1.42

1.33

1.5

12.88

7.50

ug/l

0.42

244

Psoriatic arthropathies, ICD10

225

1.47

1.31

1.2

1.5

7.68

8.56

ug/l

0.23

198

Arthropathic psoriasis

225

1.47

1.30

1.2

1.4

7.68

8.13

ug/l

0.11

198

Erosion and ectropion of cervix uteri

2.10

1.30

1.3

11.82

5.75

ug/l

—

Drug-induced osteoporosis with pathological fracture

2.37

1.29

2.0

1.2

9.52

6.06

ug/l

—

Disorders of optic nerve and visual pathways

201

1.50

1.29

1.2

1.5

8.39

7.96

ug/l

0.07

173

Acute nephritic syndrome

2.37

1.29

1.1

1.2

7.91

6.05

ug/l

—

Other specific arthropathies, wide

2.37

1.29

1.9

1.7

6.10

10.26

ug/l

—

Other keratitis

226

1.46

1.28

1.2

1.4

4.79

8.34

ug/l

2.61

198

Pulmonary heart disease, diseases of pulmonary circulation

526

1.29

1.27

1.4

1.6

9.56

9.18

ug/l

0.08

472

2.06

1.27

1.2

1.3

3.91

4.44

ug/l

—

Prolapse and hernia of ovary and fallopian tube

2.27

1.26

1.9

1.6

6.70

11.24

ug/l

—

Acute alcohol intoxication, ICD10

414

1.33

1.25

1.4

1.5

11.83

7.45

ug/l

0.48

366

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.24

1.24

1.4

7.69

6.49

ug/l

—

Anxious personality disorder

2.23

1.24

2.0

1.5

16.35

6.92

ug/l

—

Alzheimer’s disease, strict definition

220

0.60

1.24

1.6

1.5

8.04

10.77

ug/l

0.69

196

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

415

1.33

1.23

1.1

1.5

6.60

7.76

ug/l

0.47

367

Orchitis and epididymitis

123

1.63

1.23

1.5

1.3

7.39

8.91

ug/l

0.40

110

Polycystic kidney disease

2.01

1.23

1.0

1.5

7.22

8.89

ug/l

—

Other strabismus

545

1.28

1.22

1.7

1.4

6.21

6.71

ug/l

0.26

483

Colonic or urogenital fistula

556

1.28

1.22

1.4

1.5

6.14

8.01

ug/l

1.52

499

Protozoal diseases

2.05

1.22

1.2

1.3

4.75

5.99

ug/l

—

Congenital malformations of the urinary system

116

1.64

1.21

1.0

1.6

6.13

6.98

ug/l

0.34

101

Other (seronegative) rheumatoid arthritis, wide

356

1.35

1.21

1.4

1.5

7.60

8.58

ug/l

0.18

316

Coronary atherosclerosis

153

818

1.18

1.21

1.5

1.6

11.20

8.46

ug/l

0.49

138

748

Maternal care for known or suspected abnormality of pelvic organs

102

565

1.23

1.21

1.5

1.3

6.09

6.76

ug/l

0.30

500

Carbimazole or st.post thyroidectomy, condition for graves disease

487

1.30

1.20

2.0

1.5

17.36

8.05

ug/l

0.72

434

Persons encountering health services in circumstances related to reproduction

189

1097

1.16

1.19

1.9

1.5

8.53

7.09

ug/l

0.47

169

999

Heart failure and coronary heart disease

450

1.26

1.18

1.5

1.6

13.88

8.91

ug/l

0.47

414

Thiazolidinediones

173

1.51

1.17

1.9

1.6

9.48

8.13

ug/l

0.28

152

Non-ischemic cardiomyopathy

385

1.30

1.17

1.5

8.49

8.25

ug/l

0.05

357

Lesion of lateral popliteal nerve

1.78

1.17

1.1

1.6

9.36

9.77

ug/l

0.04

Glucosamine medication

102

667

1.22

1.16

1.5

1.6

14.56

9.11

ug/l

0.63

606

Other disorders of prostate

2.06

1.15

1.0

1.1

5.12

9.09

ug/l

—

Other congenital malformations of the digestive system

1.70

1.15

2.3

1.4

6.79

6.14

ug/l

0.25

Hypoplasia of dental enamel

2.51

1.15

2.6

1.9

4.30

5.53

ug/l

—

Bitten or struck by other mammals

275

1.38

1.13

1.6

1.4

6.44

7.17

ug/l

0.20

238

Anomalies of pupillary function

2.01

1.12

1.0

1.5

4.96

6.68

ug/l

—

Other infective otitis externa

111

1.63

1.12

1.2

1.7

6.53

9.94

ug/l

0.85

Other disorders of binocular movement

1.97

1.11

2.8

1.2

8.02

5.69

ug/l

—

Idiopathic thrombocytopenic purpura

1.97

1.11

1.2

1.3

12.45

5.74

ug/l

—

Other specified disorders of muscle

1.97

1.11

1.5

1.3

11.71

5.42

ug/l

—

Pneumocystosis

2.27

1.10

1.3

1.1

3.90

5.48

ug/l

—

HSIL lesion of the vagina

2.39

1.09

1.0

1.3

3.68

6.86

ug/l

—

Fracture of foot, except ankle

568

1.25

1.06

1.4

1.6

6.53

7.57

ug/l

0.29

512

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

374

1.31

1.05

1.2

1.4

6.69

7.35

ug/l

0.21

327

COPD, hospital admissions 3, with asthma pneumonia sepsis

304

1.32

1.04

1.2

1.5

10.97

9.17

ug/l

0.24

274

Myocardial infarction, strict

557

1.21

1.04

1.2

1.6

12.78

8.56

ug/l

0.49

508

Strabismus

631

1.23

1.04

1.7

1.5

7.49

6.97

ug/l

0.14

564

Carcinoma in situ of other and unspecified genital organs

2.07

1.03

1.0

1.3

4.54

5.89

ug/l

—

Other congenital malformations of the digestive system

113

1.59

1.03

2.3

1.4

6.43

5.85

ug/l

0.24

Postprocedural disorders of digestive system, not elsewhere classified

1.84

1.03

1.5

5.72

6.35

ug/l

0.14

Oral leukoplakia, including avohilmo

1.92

1.02

2.3

1.2

7.13

5.83

ug/l

—

Malignant neoplasm of bronchus and lung, including Hilmo

211

0.63

1.02

1.5

1.6

8.12

9.02

ug/l

0.18

187

Coxarthrosis, primary

133

962

1.17

1.01

1.4

1.6

7.38

9.58

ug/l

1.76

121

873

Heart failure and bmi 25plus

372

1.25

1.01

1.4

1.6

7.76

9.37

ug/l

0.58

338

108

0.46

1.00

1.2

1.5

5.02

9.36

ug/l

—

Heart failure, strict

119

710

1.18

0.99

1.5

1.6

11.48

9.22

ug/l

0.28

106

644

Other localized connective tissue disorders

1.95

0.97

1.0

1.2

6.81

6.15

ug/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

193

1346

1.14

0.97

1.6

1.5

11.88

7.31

ug/l

0.80

174

1205

Systemic sclerosis

1.81

0.96

1.0

1.7

6.50

8.23

ug/l

—

Pedestrian injured in collision with pedal cycle

1.81

0.96

1.0

1.2

5.31

5.80

ug/l

—

Suicide or other Intentional self-harm

621

1.23

0.96

1.4

1.5

10.13

7.09

ug/l

0.45

554

Arterial embolism and thrombosis

1.74

0.96

1.2

1.4

11.41

10.56

ug/l

0.05

Ulcerative colitis (strict definition, require KELA)

389

1.29

0.96

1.2

1.5

6.60

7.65

ug/l

0.38

341

Toxic liver disease

0.00

0.95

0.0

1.3

—

6.29

—

Benign neoplasm: Skin of ear and external auricular canal

1.78

0.94

1.4

1.2

6.82

7.71

ug/l

0.11

Disorders of acoustic nerve

1.90

0.94

1.3

1.2

6.67

6.37

ug/l

—

Portal vein thrombosis

2.23

0.93

1.2

1.4

5.10

6.38

ug/l

—

Type 2 diabetes, strict (exclude DM1)

287

1520

1.11

0.93

1.4

1.5

8.48

7.76

ug/l

0.31

258

1374

Hypertensive heart and/or renal disease

264

1.30

0.93

1.6

11.91

9.59

ug/l

0.39

245

False labour

123

655

1.17

0.92

1.6

1.4

6.72

7.16

ug/l

0.14

110

584

Maternal care for known or suspected malpresentation of fetus

444

1.23

0.92

1.7

1.3

6.78

5.76

ug/l

0.52

394

Systemic sclerosis, icd10

1.74

0.92

1.0

1.6

6.50

8.17

ug/l

—

Acute epiglottitis

2.15

0.91

1.3

1.2

8.70

5.97

ug/l

—

Iridocyclitis in diseases classified elsewhere

2.15

0.91

1.5

1.3

5.07

6.34

ug/l

—

Spontaneous abortion

159

936

1.15

0.91

1.5

1.4

6.70

7.35

ug/l

0.33

142

847

Organic, including symptomatic, mental disorders

632

0.82

0.90

1.4

1.5

9.52

9.73

ug/l

0.04

574

Complications predominantly related to the puerperium

754

1.20

0.90

1.7

1.4

7.88

6.90

ug/l

0.32

675

Type 2 diabetes

307

1627

1.10

0.90

1.4

1.5

8.55

7.67

ug/l

0.41

277

1472

Benign neoplasm: Skin of lip

2.08

0.89

1.3

1.2

4.48

6.26

ug/l

—

Whooping cough

2.08

0.89

1.2

3.85

6.47

ug/l

—

Pulmonary embolism

492

1.24

0.89

1.5

1.6

8.62

9.48

ug/l

0.27

440

Alcoholic liver disease

155

0.58

0.88

1.2

1.5

10.72

8.80

ug/l

—

138

Disorder of lipoprotein metabolism, unspecified

194

1.39

0.88

1.4

5.92

7.39

ug/l

0.90

171

Secondary right heart disease

1.79

0.88

1.8

1.4

15.56

8.98

ug/l

—

All-cause Heart Failure

116

701

1.17

0.87

1.5

1.6

11.66

9.28

ug/l

0.29

103

636

Pulmonary heart disease

493

1.24

0.87

1.5

1.6

8.62

9.47

ug/l

0.26

440

L01XX Other antineoplastic agents

1.61

0.87

3.1

1.5

12.69

11.11

ug/l

0.12

Hypersomnia

2.01

0.87

1.2

1.3

6.18

6.72

ug/l

—

Other salmonella infections

1.72

0.86

1.3

1.4

8.35

5.66

ug/l

0.56

Other and unspecified intracranial injuries

1.82

0.86

1.0

1.4

4.19

6.32

ug/l

—

Erosion of teeth , including avohilmo

642

1.20

0.83

1.3

1.5

5.56

7.01

ug/l

1.30

573

Contraceptive management

137

838

1.15

0.82

1.7

1.5

8.70

7.08

ug/l

0.27

125

760

SLE (Finngen)

1.70

0.82

1.1

1.6

4.48

7.93

ug/l

1.13

Other (not insulin) diabetes medications

290

1567

1.10

0.81

1.4

1.5

8.36

7.82

ug/l

0.23

262

1417

Other maternal disorders predominantly related to pregnancy

201

1127

1.12

0.81

1.5

7.76

7.23

ug/l

0.15

178

1015

Type 2 diabetes, definitions combined

284

1518

1.10

0.81

1.4

1.5

8.48

7.77

ug/l

0.30

255

1372

Dipeptidyl peptidase 4 (DPP-4) inhibitors

125

871

1.15

0.79

1.4

1.6

8.05

9.21

ug/l

0.67

115

794

Nonischemic cardiomyopathy

147

1.43

0.79

1.4

9.45

8.24

ug/l

0.14

133

Brain glioblastoma

0.00

0.79

0.0

1.3

—

7.41

—

Malignant cancer of tonsil and base of tongue, including Hilmo

1.82

0.79

1.2

1.4

5.28

5.91

ug/l

—

Renal cell carcinoma of kidney

1.82

0.79

1.5

6.37

10.37

ug/l

—

Lung cancer and mesothelioma

202

0.68

0.79

1.5

8.12

9.02

ug/l

0.18

189

Other, unspecified and serous retinal detachments

1.67

0.79

1.5

1.4

12.66

6.61

ug/l

—

Malignant neoplasm of urinary organs

106

1.51

0.78

1.6

8.36

9.07

ug/l

0.11

Small cell lung cancer, helper endpoint

0.00

0.78

0.0

1.1

—

5.55

—

Intracerebral haemorrhage

150

0.60

0.78

1.1

1.5

4.66

9.95

ug/l

—

129

Schizophrenia or delusion, excluding more controls

645

0.81

0.78

1.6

1.5

6.48

7.14

ug/l

0.29

584

Malignant neoplasm of tongue

0.00

0.77

0.0

1.1

—

5.41

—

Superficial injury of forearm

234

1.33

0.77

1.5

5.04

7.12

ug/l

1.37

206

Other and unspecified nonorganic psychotic disorders

473

0.78

0.77

1.6

1.4

6.50

7.13

ug/l

0.19

420

Complications associated with artificial fertilization

1.77

0.76

1.2

1.5

7.18

7.57

ug/l

—

Deficiency of other B group vitamins

1.77

0.76

1.0

1.2

3.90

6.36

ug/l

—

Disorder of external ear, unspecified

1.70

0.76

1.2

1.3

5.14

5.84

ug/l

—

Other specified disorders of external ear

1.70

0.76

2.4

1.3

7.57

8.77

ug/l

—

Testicular hypofunction

1.70

0.75

2.8

1.2

11.21

8.14

ug/l

—

Deep bite that required surgery

2.09

0.74

1.0

1.3

5.04

7.20

ug/l

—

Inflammation of lacrimal passages (chronic)

2.09

0.74

2.6

1.1

6.36

5.57

ug/l

—

Medical abortion

214

1047

1.11

0.74

1.7

1.4

9.90

7.40

ug/l

0.67

195

951

Chronic Coagulation defects

1.64

0.73

1.1

1.5

7.51

6.31

ug/l

—

Antepartum haemorrhage, not elsewhere classified

245

1.31

0.73

1.4

5.66

6.29

ug/l

0.25

216

Malignant neoplasm of kidney, except renal pelvis

100

1.50

0.72

1.7

1.6

8.49

9.07

ug/l

0.08

Presbycusis

132

1.43

0.72

1.7

1.4

10.06

8.45

ug/l

0.23

117

Otosclerosis

125

1.44

0.72

1.2

1.5

6.92

8.57

ug/l

0.45

106

Nontraumatic intracranial haemmorrhage

288

0.73

0.72

1.6

1.5

24.02

9.17

ug/l

0.41

254

Follow-up care involving plastic surgery

1.55

0.72

1.0

1.6

5.02

7.42

ug/l

0.84

COPD, hospital admissions

630

1.17

0.71

1.4

1.6

10.15

9.65

ug/l

0.08

572

HSIL lesion of the vulva

1.93

0.70

1.0

1.8

4.92

6.84

ug/l

—

Alcohol use disorder, ICD-based

902

0.85

0.70

1.6

1.5

6.92

8.67

ug/l

0.81

812

Retinal detachments and breaks

637

1.18

0.70

1.9

1.5

12.26

8.98

ug/l

0.48

578

Persistent delusional disorders

145

0.62

0.69

2.1

1.6

9.34

9.73

ug/l

—

127

Other disorders of cornea

169

1.36

0.69

1.9

1.5

7.43

8.45

ug/l

0.15

145

Convergence insufficiency and excess

1.86

0.68

2.4

1.3

3.54

6.79

ug/l

—

Injury of nerves at wrist and hand level

1.60

0.68

2.0

1.3

6.78

7.71

ug/l

0.15

Muscle strain

1.53

0.68

1.3

5.04

5.80

ug/l

—

Alcohol use disorder, Swedish definition

110

1148

0.88

0.68

1.5

8.26

8.09

ug/l

0.05

100

1035

Dysplasia of cervi uteri

461

1.18

0.68

1.4

6.49

7.06

ug/l

0.15

407

Medical treatment for female infertility

654

1.17

0.67

1.5

1.4

6.09

6.28

ug/l

0.08

584

Periapical abscess

124

1098

1.13

0.67

1.6

1.5

8.39

8.56

ug/l

0.05

112

988

Other lack of coordination

1.79

0.66

1.2

1.3

11.16

6.99

ug/l

—

Inflammation of lacrimal passages (acute and unspecified)

1.79

0.66

1.0

1.3

4.04

5.48

ug/l

—

COPD, early/later onset

633

1.16

0.66

1.4

1.6

10.15

9.64

ug/l

0.08

575

Oesophagitis

1.54

0.65

1.3

1.5

8.65

8.45

ug/l

0.02

Other and unspecified disease of Bartholin gland

1.59

0.65

1.7

2.0

9.60

11.26

ug/l

—

All dysplastic lesions of the vagina

1.62

0.65

6.3

1.6

40.31

7.64

ug/l

—

Embedded and impacted teeth

698

1.15

0.64

1.2

1.4

6.94

6.38

ug/l

0.09

613

Thyroiditis, unspecified

1.73

0.64

2.0

1.3

4.30

5.49

ug/l

—

Perichondritis of external ear

1.73

0.64

1.0

1.2

5.94

6.27

ug/l

—

Toxic effect of ethanol

1.52

0.62

1.0

1.4

7.44

7.41

ug/l

0.00

Neovascular glaucoma

1.59

0.61

2.4

1.4

10.66

6.59

ug/l

—

Glaucoma secondary to other eye disorders

1.59

0.61

2.4

1.4

10.66

7.79

ug/l

—

COPD (mode)

325

1.21

0.61

1.2

1.6

10.44

8.86

ug/l

0.20

303

Family history of other conditions

1.67

0.61

6.8

1.3

48.04

5.72

ug/l

—

Alcohol withdrawal state with delirium

105

0.57

0.61

3.0

1.7

20.65

9.31

ug/l

—

Pyoderma

1.67

0.61

1.0

1.3

6.46

6.95

ug/l

—

Malignant neoplasm of other and unspecified parts of tongue

0.00

0.60

0.0

1.2

—

5.35

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

968

0.87

0.60

1.6

1.5

7.54

8.48

ug/l

0.36

877

Other salmonella infections

1.50

0.59

1.2

1.4

8.07

5.70

ug/l

0.53

Other congenital malformations of circulatory system

1.54

0.59

1.1

1.2

4.72

6.34

ug/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

114

1.41

0.58

1.6

1.7

8.42

8.99

ug/l

0.09

Chorioretinal inflammation

1.51

0.58

1.0

1.4

5.22

5.98

ug/l

—

Small cell lung cancer, including Hilmo

0.00

0.58

0.0

1.1

—

6.53

—

Small cell lung cancer

0.00

0.58

0.0

1.1

—

6.53

—

Embolic stroke with flimmer

0.00

0.58

0.0

1.1

—

9.73

—

Hypertensive Heart Disease

248

1.23

0.58

1.6

10.56

9.00

ug/l

0.23

230

Diabetes medication

320

1770

1.07

0.57

1.4

1.5

9.17

7.63

ug/l

0.70

288

1606

Lung diseases due to external agents

184

1.31

0.57

1.2

1.5

6.28

9.45

ug/l

1.38

159

Other chronic obstructive pulmonary disease, including avohilmo

109

800

1.13

0.57

1.4

1.6

9.57

9.45

ug/l

0.02

725

Insulin, intermediate and long-acting

130

1135

1.11

0.57

1.2

1.6

12.51

8.19

ug/l

0.66

121

1024

Congenital deformities of feet

1.49

0.57

1.4

1.5

4.09

6.33

ug/l

—

Non-small cell lung cancer, including Hilmo

163

0.69

0.57

1.2

1.7

5.57

9.86

ug/l

1.66

143

Benign neoplasm of other and unspecified female genital organs

1.49

0.57

1.3

1.7

6.37

8.88

ug/l

0.61

Congenital malformations of breast

1.67

0.57

1.2

1.3

5.08

5.87

ug/l

—

Undefined dementia

0.56

2.4

1.4

11.82

9.95

ug/l

—

Unspecified dementia

0.55

0.56

2.4

1.6

11.82

11.37

ug/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

172

1186

1.10

0.55

1.6

1.5

12.41

6.92

ug/l

0.88

155

1058

Supervision of high-risk pregnancy

419

1.15

0.55

1.4

6.35

5.98

ug/l

0.17

382

Pregnancy examination and test

329

1.17

0.54

1.3

4.74

5.70

ug/l

0.76

297

Benign neoplasm: Vulva

1.58

0.54

1.5

1.8

8.08

9.62

ug/l

—

Benign neoplasm of brain and other parts of central nervous system

116

1.38

0.54

1.9

1.5

13.57

7.15

ug/l

0.54

Pneumonia due to other infectious organisms, not elsewhere classified

1.50

0.54

1.4

3.69

8.15

ug/l

—

Excessive earwax

132

1164

1.11

0.54

1.5

1.6

11.35

8.44

ug/l

0.35

123

1054

Mucosal proctocolitis

285

1.23

0.54

1.2

1.5

8.10

7.49

ug/l

0.14

250

Acute alcohol intoxication

515

1.17

0.53

1.4

1.5

12.19

8.10

ug/l

0.48

458

Chronic periodontitis, complicated

131

1174

1.11

0.53

1.6

1.5

13.45

8.72

ug/l

0.65

113

1071

Dislocation, sprain and strain of joints and ligaments of thorax

1.45

0.53

2.1

1.5

5.58

7.75

ug/l

—

Rubella [German measles]

1.54

0.53

4.7

1.3

10.80

7.64

ug/l

—

Use of selegiline

1.45

0.53

2.4

1.4

7.94

8.93

ug/l

—

Malignant neoplasm of eye, brain and central nervous system

1.45

0.53

1.1

1.8

4.36

11.45

ug/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.43

0.52

1.4

1.2

9.86

7.70

ug/l

—

Tooth agenesis EXCLUDE clefts and syndromes

0.62

0.52

1.0

1.4

3.43

6.74

ug/l

—

Vestibular neuronitis

152

1.32

0.52

2.2

1.6

16.37

9.71

ug/l

0.46

127

Drug-induced neutropenia

132

0.68

0.51

2.0

1.5

14.30

8.68

ug/l

—

114

Male infertility

1.45

0.51

1.8

1.5

7.28

8.23

ug/l

0.16

Congenital malformations of breast

1.50

0.51

1.2

1.3

5.08

5.76

ug/l

—

Pemphigoid

1.50

0.51

1.3

1.2

4.40

6.23

ug/l

—

Obstructed labour due to malposition and malpresentation of fetus

648

1.14

0.51

1.8

1.4

9.18

6.78

ug/l

0.34

576

Leiomyoma of uterus

186

969

1.09

0.51

1.4

1.5

8.01

7.87

ug/l

0.04

165

874

Malignant neoplasm of breast, including Hilmo

670

0.89

0.51

1.4

1.5

7.59

8.31

ug/l

0.22

593

Malignant neoplasm of breast, HER2-negative, including Hilmo

670

0.89

0.50

1.4

1.5

7.59

8.31

ug/l

0.22

593

Follicular lymphoma, hilmo

1.39

0.50

2.9

1.5

16.18

8.14

ug/l

—

Hirsutism in women

1.47

0.50

1.0

1.5

4.77

6.44

ug/l

—

Pedestrian injured in collision with car, pick-up truck or van

1.47

0.50

1.2

1.3

3.53

7.07

ug/l

—

Foreign body entering into or through eye or natural orifice

153

1.31

0.50

1.7

1.5

5.67

8.66

ug/l

1.17

134

Obstructed labour due to maternal pelvic abnormality

362

1.19

0.49

1.8

1.4

9.31

8.38

ug/l

0.18

328

Alzheimer’s disease (Late onset), excluding more controls

110

0.71

0.48

1.8

9.28

13.11

ug/l

0.52

102

Impacted teeth

554

1.14

0.48

1.2

1.5

7.87

6.48

ug/l

0.17

481

Single delivery by caesarean section

391

0.86

0.48

1.5

5.61

6.78

ug/l

0.39

351

Other encephalitis

1.49

0.47

1.0

1.3

8.50

6.12

ug/l

—

Benign neoplasm: Cranial nerves

1.46

0.47

1.3

6.67

5.78

ug/l

—

132

1272

0.91

0.46

1.5

9.74

7.95

ug/l

0.42

119

1153

Aneurysms, operations, SAH

291

1.20

0.46

1.8

1.6

19.69

8.88

ug/l

0.53

255

Later onset COPD

282

0.82

0.46

1.1

1.5

10.09

10.08

ug/l

0.00

259

Inflammatory disease of cervix uteri

118

0.68

0.45

1.4

1.5

7.11

8.03

ug/l

—

100

Normotensive glaucoma

121

0.66

0.45

1.5

1.4

8.94

9.85

ug/l

—

103

Congenital malformations of uterus and cervix

1.40

0.45

1.1

1.6

4.53

5.76

ug/l

—

Injuries involving multiple body regions

1.45

0.44

1.9

1.4

28.87

6.04

ug/l

—

Other disorders of amniotic fluid and membranes

404

1.16

0.43

1.5

1.4

6.39

6.13

ug/l

0.08

358

Other and unspecified psoriasis

113

1.33

0.42

1.4

1.6

9.57

9.03

ug/l

0.08

LSIL lesion of the vagina

1.57

0.42

10.0

1.3

67.68

6.69

ug/l

—

Fracture of shoulder and upper arm

744

1.11

0.42

1.9

1.5

12.16

7.70

ug/l

0.80

666

Benign neoplasm of other and unspecified sites

1.41

0.42

1.0

1.6

4.28

7.80

ug/l

—

Traumatic amputation of wrist and hand

1.41

0.42

1.5

1.3

7.90

9.83

ug/l

—

Biguanides

270

1550

1.06

0.42

1.3

1.5

7.56

8.15

ug/l

0.39

245

1399

Cardiodefibrillation

555

1.13

0.41

1.7

1.5

18.59

9.09

ug/l

0.77

508

Bacterial sepsis of newborn

0.00

0.41

0.0

2.1

—

4.91

—

Paranoid personality disorder

1.52

0.41

1.4

1.2

5.92

6.50

ug/l

—

Cervical root disorders

0.00

0.41

0.0

1.4

—

7.64

—

Intercostal neuropathy

0.00

0.41

0.0

1.3

—

7.46

—

Abnormal findings on diagnostic imaging of central nervous system

105

1.34

0.41

1.3

1.5

7.23

7.19

ug/l

0.01

Malignant neoplasm of stomach, including Hilmo

1.36

0.41

1.5

1.6

5.38

9.74

ug/l

—

Other congenital malformations of male genital organs

0.00

0.41

0.0

1.6

—

5.55

—

Other congenital malformations of male genital organs

0.00

0.41

0.0

1.6

—

5.55

—

Systemic lupus erythematosus

1.40

0.40

1.1

1.7

4.48

7.84

ug/l

1.27

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.00

0.40

0.0

1.3

—

6.92

—

Intermittent heterotropia

138

0.72

0.40

1.8

1.4

3.73

6.24

ug/l

—

117

Thoracic aortic aneurysm

204

1.23

0.40

1.4

1.7

5.37

10.63

ug/l

2.72

182

Somnolence, stupor and coma

1.33

0.40

2.5

1.5

6.65

8.38

ug/l

—

Diabetes, varying definitions

313

1739

1.06

0.40

1.4

1.5

9.33

7.58

ug/l

0.80

281

1576

125

1227

0.92

0.40

1.5

10.01

8.00

ug/l

0.45

112

1111

Moderate visual impairment, binocular

1.43

0.39

1.0

1.2

6.32

5.98

ug/l

—

Pneumonitis due to solids and liquids

106

0.66

0.39

1.0

1.6

4.81

11.43

ug/l

—

Open wound of head

128

1138

1.08

0.38

1.7

1.5

9.52

8.21

ug/l

0.37

115

1032

Gingival hyperplasia

1.37

0.38

1.2

1.3

4.84

6.04

ug/l

—

Burn and corrosion of wrist and hand

1.33

0.37

3.0

1.6

14.41

6.32

ug/l

—

All dysplastic lesions of the vulva

1.33

0.37

3.9

1.9

29.71

9.47

ug/l

0.39

Mental and behavioural disorders due to alcohol

109

1140

0.92

0.37

1.5

9.67

8.13

ug/l

0.28

1033

Diabetes mellitus

315

1750

1.05

0.37

1.4

1.5

9.30

7.58

ug/l

0.79

283

1585

Erectile dysfunction

1.33

0.37

1.4

1.7

6.97

9.44

ug/l

0.58

conjunctival degenerations and deposits

1.35

0.37

1.4

1.5

4.52

9.20

ug/l

—

Other disorders of iris and ciliary body

1.35

0.37

1.0

1.2

6.76

9.37

ug/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

114

0.70

0.37

1.3

1.4

5.64

7.06

ug/l

—

100

Substance abuse, excluding more controls

136

1075

1.08

0.36

1.5

8.87

8.22

ug/l

0.13

119

973

L02BG Aromatase inhibitors

638

1.11

0.36

1.3

1.6

7.98

8.70

ug/l

0.19

581

Labour and delivery complicated by fetal stress [distress]

551

0.90

0.36

1.6

1.4

5.70

6.18

ug/l

0.26

485

Contact with nonpowered hand tool

1.27

0.36

2.9

1.3

7.06

8.26

ug/l

—

Burn and corrosion of hip and lower limb, except ankle and foot

1.43

0.35

1.3

5.27

6.47

ug/l

—

All dysplastic lesions of the cervix uteri

800

0.90

0.35

1.4

6.41

6.84

ug/l

0.11

714

Suppurative otitis media, unspecified

1.40

0.35

1.0

1.3

4.35

5.82

ug/l

—

Cerebrovascular diseases

165

1085

1.07

0.34

1.3

1.6

10.20

8.63

ug/l

0.28

156

984

Later onset COPD, excluding more controls

189

1.19

0.34

1.1

1.5

10.09

9.42

ug/l

0.06

179

Other and unspecified nail disorders

1.37

0.34

1.2

1.8

4.52

8.85

ug/l

—

Papilloedema, unspecified

1.37

0.34

1.0

1.4

5.10

6.57

ug/l

—

Burn and corrosion confined to eye and adnexa

1.37

0.34

1.0

1.5

3.97

9.84

ug/l

—

Isolated proteinuria

1.34

0.33

2.3

1.2

19.70

6.84

ug/l

—

Injury of muscle and tendon at ankle and foot level

1.31

0.33

1.2

1.3

7.18

6.06

ug/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

274

1571

1.05

0.33

1.4

1.5

11.37

7.77

ug/l

1.17

248

1427

Dilated cardiomyopathy

173

1.21

0.32

1.4

1.6

9.56

9.88

ug/l

0.03

152

Periodontal disease, other/unspecified

1.28

0.32

1.3

1.5

5.40

7.13

ug/l

—

Superficial injuries involving multiple body regions

1.28

0.32

2.3

1.4

8.83

6.61

ug/l

—

Diabetic retinopathy, excluding more controls

280

1.12

0.32

1.5

1.4

23.69

7.96

ug/l

1.06

254

Supervision of normal pregnancy

435

0.91

0.32

1.7

1.4

14.23

5.93

ug/l

0.66

396

Encephalitis

1.35

0.31

1.0

1.3

8.50

5.99

ug/l

—

Coxarthrosis, primary, with hip surgery

775

1.09

0.31

1.5

1.6

7.53

9.79

ug/l

1.34

706

COPD related to multimorbidity

521

1.10

0.31

1.3

1.6

10.89

10.04

ug/l

0.12

479

Sixth [abducent] nerve palsy

1.32

0.31

2.4

1.3

20.36

7.62

ug/l

—

Distal bite

1.30

0.30

1.2

1.6

4.02

5.96

ug/l

2.33

Burn and corrosion of trunk

1.27

0.30

2.7

1.3

5.67

6.73

ug/l

—

Other obstructive and reflux uropathy

1.31

0.30

1.2

1.4

40.02

5.70

ug/l

0.46

Disorders of speech understanding and production

100

1.28

0.30

1.5

5.40

5.35

ug/l

0.02

Diabetic retinopathy

373

1.10

0.30

1.5

1.3

21.38

8.05

ug/l

1.11

344

Lesion of sciatic nerve

1.25

0.29

1.4

1.5

10.30

11.15

ug/l

—

Malignant neoplasm of rectum

110

0.73

0.28

1.0

1.7

3.39

8.99

ug/l

—

Mental disorders, not otherwise specified

204

1.18

0.28

1.5

1.4

7.34

6.84

ug/l

0.08

179

Sub-endpoint used in defining T1D endpoints

617

0.91

0.28

1.1

1.5

18.97

7.23

ug/l

0.84

548

Complications of labour and delivery

201

1062

1.05

0.27

1.6

1.4

8.23

7.56

ug/l

0.19

182

955

Substance use, excluding alcohol

470

1.11

0.27

1.7

1.5

12.08

7.31

ug/l

0.49

418

Delivery, wide proxy

101

499

1.08

0.26

1.6

1.4

6.94

7.65

ug/l

0.19

446

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

225

0.84

0.26

1.3

1.5

13.02

8.73

ug/l

0.70

199

Use of galantamine

0.69

0.26

1.6

1.4

4.44

10.51

ug/l

—

Persons with potential health hazards related to communicable diseases

121

1128

1.06

0.26

1.3

1.4

6.88

6.45

ug/l

0.19

100

1030

Tuberculosis

0.68

0.26

3.0

1.5

8.12

11.41

ug/l

—

Diabetes, insulin treatment (Kela reimbursement)

284

1648

1.04

0.25

1.4

1.5

11.29

7.76

ug/l

1.20

257

1495

Chronic hepatitis, not elsewhere classified

1.25

0.25

1.1

1.6

4.56

8.32

ug/l

—

LSIL lesion of the vulva

1.23

0.25

5.2

1.9

40.47

9.05

ug/l

—

Nonspecific lymphadenitis

123

1.22

0.25

1.6

6.45

7.77

ug/l

0.27

106

Other diseases of gallbladder

1.22

0.25

1.3

1.4

6.93

8.85

ug/l

—

ILD, hospital admissions 3, with pneumonia sepsis

114

1.23

0.25

2.0

1.6

8.69

10.38

ug/l

0.30

Impotence

1.20

0.25

1.2

1.3

6.76

8.38

ug/l

—

Long labour

666

0.92

0.24

1.2

1.3

5.15

7.02

ug/l

1.46

593

Inguinal hernia

134

846

1.06

0.24

1.5

1.6

6.96

8.86

ug/l

1.07

124

764

SLE, ICD10

1.17

0.24

1.0

1.4

4.40

6.02

ug/l

—

SLE, strict definition

1.17

0.24

1.0

1.4

4.40

6.02

ug/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.72

0.24

1.0

1.5

5.55

11.24

ug/l

—

Dementia in Alzheimer disease

143

0.83

0.24

2.1

1.4

10.88

9.57

ug/l

0.18

126

Malignant neoplasm of breast

662

0.94

0.24

1.4

1.5

8.11

8.34

ug/l

0.06

587

Malignant neoplasm of breast, HER2-negative

650

0.94

0.23

1.4

1.5

8.15

8.39

ug/l

0.06

576

Fracture of forearm

148

1289

1.05

0.23

1.7

1.5

11.24

7.73

ug/l

0.75

133

1161

COPD, hospital admissions 1, only main diagnosis

448

1.09

0.23

1.3

1.5

9.89

9.04

ug/l

0.13

411

Certolizumab pegol

1.28

0.23

1.2

1.3

5.70

6.50

ug/l

—

Assault by unspecified means

1.28

0.23

1.0

1.3

2.64

10.28

ug/l

—

Loose body in joint

1.28

0.23

1.6

10.40

11.17

ug/l

—

Dissection of aorta

1.28

0.23

1.0

1.3

3.90

9.32

ug/l

—

Infective bursitis

1.25

0.22

1.4

1.3

5.60

5.92

ug/l

—

Abdominal aortic aneurysm (AAA)

0.75

0.22

1.1

1.3

10.01

9.42

ug/l

—

Postpartum hemorraghe, parous women as controls

677

1.07

0.22

1.4

5.58

7.27

ug/l

0.78

604

Alzheimer disease, excluding more controls

146

0.86

0.22

1.5

1.8

8.14

11.57

ug/l

0.61

134

Molar incisor enamel hypoplasia

1.25

0.22

2.5

1.7

6.05

5.38

ug/l

0.11

Fall involving bed

1.22

0.22

2.8

1.4

10.72

6.08

ug/l

—

Pregnancy with abortive outcome

211

1056

1.04

0.22

1.7

1.4

9.75

7.37

ug/l

0.53

187

958

Antenatal screening

446

0.93

0.21

1.9

1.4

13.76

5.96

ug/l

0.71

406

Cleft lip

0.00

0.21

0.0

2.0

—

8.23

—

Maxillary hypoplasia

0.00

0.21

0.0

1.2

—

6.23

—

Other disorders following mastoidectomy

0.00

0.21

0.0

1.0

—

5.31

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.21

0.0

1.3

—

7.00

—

Exposure to ignition of highly flammable material

0.00

0.21

0.0

1.1

—

6.04

—

Sequelae of burns, corrosions and frostbite

0.00

0.21

0.0

1.1

—

6.29

—

Abnormality of red blood cells

0.00

0.21

0.0

1.4

—

7.34

—

Injury of nerves and spinal cord at thorax level

0.00

0.21

0.0

1.4

—

7.49

—

Ectopic testis

0.00

0.21

0.0

1.9

—

5.72

—

Arteriovenous malformation of peripheral vessels

0.00

0.21

0.0

1.4

—

7.94

—

Follicular adenocarcinoma of thyroid gland

0.00

0.21

0.0

1.7

—

8.49

—

Other and unspecified neuropathies

0.00

0.21

0.0

1.4

—

7.69

—

Cleft lip and palate

0.00

0.21

0.0

1.4

—

7.78

—

Injury of other and unspecified intrathoracic organs

101

0.79

0.21

2.5

1.2

16.09

8.91

ug/l

—

Non-small cell lung cancer

101

0.79

0.21

1.0

1.7

5.39

9.27

ug/l

—

Certain zoonotic bacterial diseases

1.16

0.21

2.0

1.2

8.34

6.02

ug/l

—

Meckel's diverticulum

0.00

0.21

0.0

1.3

—

6.92

—

Cleft lip and cleft lip and palate

0.00

0.21

0.0

1.8

—

7.69

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

0.00

0.21

0.0

1.0

—

4.92

—

Malignant neoplasm of breast, ER-positive, including Hilmo

533

1.07

0.20

1.3

1.5

7.78

8.94

ug/l

0.30

471

Insulin, combination of fast acting with intermediate-acting or long-acting

141

1229

1.05

0.20

1.2

1.6

11.96

8.17

ug/l

0.60

129

1115

Malignant neoplasm of breast, HER-positive

524

1.07

0.20

1.3

1.5

7.82

8.96

ug/l

0.29

463

Congenital dislocation of hip, unilateral

0.00

0.20

0.0

1.6

—

6.20

—

Carcinoma in situ of other and unspecified digestive organs

1.25

0.20

1.3

1.2

4.07

6.98

ug/l

—

Slow fetal growth and fetal malnutrition

0.00

0.20

0.0

2.6

—

4.89

—

Hypertrichosis

1.23

0.20

1.0

1.6

4.77

6.54

ug/l

—

Dislocation, sprain and strain of joint and ligaments of hip

1.23

0.20

1.0

1.4

5.67

8.04

ug/l

—

Ovarian hyperstimulation (induction)

1.16

0.19

1.2

1.5

7.18

5.93

ug/l

—

Other disorders of bone density and structure

1.15

0.19

1.8

1.2

62.75

6.22

ug/l

—

Status epilepticus

1.15

0.19

1.0

1.6

5.75

8.07

ug/l

—

Clear cell adenocarcinoma of kidney

1.15

0.19

2.2

1.7

11.87

10.18

ug/l

—

Malignant neoplasm of stomach

1.15

0.19

1.3

1.6

4.57

10.50

ug/l

—

Benign neoplasm of middle ear and respiratory system

122

0.82

0.19

1.3

1.6

9.63

9.88

ug/l

—

106

Pedal cyclist injured in transport accident

521

1.08

0.18

1.4

1.5

8.98

7.30

ug/l

0.38

464

Pregnancy, childbirth and the puerperium

408

1.06

0.18

1.5

1.4

5.68

6.41

ug/l

0.40

371

Use of ropinirole

1.21

0.18

1.7

1.4

5.57

8.64

ug/l

—

Haemolytic anaemias

1.19

0.18

2.4

1.3

24.64

5.75

ug/l

—

Type 1 diabetes

589

0.93

0.18

1.1

1.5

19.48

7.16

ug/l

0.85

533

Maternal care related to the fetus and amniotic cavity and possible delivery problems

144

881

0.96

0.17

1.5

6.16

7.60

ug/l

0.88

127

790

Oesophageal varices

1.15

0.17

1.4

1.5

13.86

7.34

ug/l

—

Ulcerative enterocolitis

1.13

0.17

1.1

1.4

9.69

5.85

ug/l

—

Hepatic failure, not elsewhere classified

1.13

0.17

1.3

1.4

7.07

8.54

ug/l

—

Gestational diabetes (for exclusion)

134

893

1.04

0.17

1.6

1.4

7.05

6.83

ug/l

0.04

120

793

Benign neoplasm of thyroid gland

0.76

0.17

1.4

1.5

5.58

7.72

ug/l

—

Car occupant injured in noncollision transport accident

0.73

0.17

1.4

1.3

46.32

8.21

ug/l

—

Benign neoplasm: Rectosigmoid junction

0.72

0.17

1.2

1.4

4.40

8.66

ug/l

—

Single spontaneous delivery

111

616

0.95

0.16

1.6

1.5

6.99

7.83

ug/l

0.27

554

Systemic lupus erythematosus, unspecified

1.16

0.16

1.0

1.4

4.17

5.84

ug/l

—

Spasmodic torticollis

1.14

0.16

1.5

1.6

6.44

7.74

ug/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.14

0.16

3.0

1.5

9.50

5.63

ug/l

—

Malignant neoplasm of colon

162

0.86

0.16

1.2

1.5

4.56

8.30

ug/l

3.15

143

All dysplastic lesions of the cervix uteri, vagina or vulva

901

0.95

0.16

1.9

1.4

10.67

7.10

ug/l

0.42

797

Calculus of lower urinary tract

1.13

0.16

1.5

1.3

13.20

9.67

ug/l

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.78

0.16

2.2

1.9

12.27

12.88

ug/l

—

Female infertility, tubal origin

111

1.17

0.15

1.2

1.4

6.54

6.45

ug/l

0.02

101

Other aneurysm

1.10

0.15

2.1

1.6

13.43

11.41

ug/l

—

Alzheimer’s disease (Atypical or mixed)

0.78

0.15

2.2

1.3

12.27

10.35

ug/l

—

Agoraphobia

1.15

0.15

1.0

1.4

4.17

7.20

ug/l

—

Corneal ulcer

400

1.08

0.15

1.4

1.5

7.51

7.91

ug/l

0.06

354

Left ventricular outflow tract obstruction, narrow definition

1.11

0.15

1.0

1.5

5.56

8.25

ug/l

—

Maternal care for other known or suspected fetal problems

543

1.05

0.15

1.5

1.4

5.74

6.57

ug/l

0.39

481

Substance abuse

136

1325

0.96

0.14

1.5

8.87

7.96

ug/l

0.19

119

1206

Subarachnoid haemorrhage

150

0.87

0.14

1.8

1.5

35.78

8.48

ug/l

0.48

130

Tuberculosis, IBD comorbidity

0.79

0.14

2.4

1.4

7.93

10.23

ug/l

—

Focal brain injury

0.79

0.14

2.6

1.6

20.93

9.28

ug/l

—

Tuberculosis, wide

0.79

0.14

2.4

1.4

7.93

10.51

ug/l

—

Mental and behavioural disorders due to psychoactive substance use

142

1362

0.97

0.14

1.5

8.93

7.88

ug/l

0.23

123

1240

Mental and behavioural disorders due to opioids

1.19

0.14

3.7

1.3

34.16

7.66

ug/l

—

Open bite

141

1.14

0.14

1.2

1.5

3.84

6.19

ug/l

1.86

118

Pyogenic arthritis

103

1.17

0.13

1.3

1.6

10.19

8.62

ug/l

0.13

Ill-defined and unknown causes of mortality

106

0.85

0.13

1.3

1.5

6.18

10.26

ug/l

—

Varicose veins

139

1016

1.03

0.12

1.5

9.33

8.92

ug/l

0.09

125

924

Malignant neoplasm of thyroid gland, including Hilmo

133

1.13

0.12

1.5

1.4

6.93

7.51

ug/l

0.14

110

Paralytic strabismus

116

0.86

0.12

2.0

1.5

15.90

6.94

ug/l

—

101

Disorders of choroid and retina

189

1309

1.03

0.11

1.4

1.5

11.10

8.58

ug/l

0.50

172

1189

Postpartum hemorraghe, all women as controls

805

1.04

0.11

1.4

5.58

6.66

ug/l

0.48

718

Traumatic subdural haemorrhage

138

1.11

0.10

2.9

1.7

21.24

10.99

ug/l

0.36

126

Drug-induced cataract

1.14

0.10

1.2

1.5

5.12

6.03

ug/l

—

Benign neoplasm: Anus and anal canal

1.14

0.10

1.0

1.4

4.96

6.02

ug/l

—

Primary ovarian failure

1.06

0.09

10.4

1.6

74.44

6.23

ug/l

—

Medicines for HER+ breast cancer

788

1.03

0.09

1.3

1.5

7.42

8.85

ug/l

0.52

714

Contact with and exposure to communicable diseases

945

0.97

0.09

1.2

1.4

6.24

6.18

ug/l

0.03

857

Motorcycle rider injured in noncollision transport accidents

1.09

0.09

2.0

1.3

4.82

8.56

ug/l

—

Alcohol-induced acute pancreatitis

1.09

0.09

1.5

11.17

9.14

ug/l

—

Other specified and unspecified retinal disorders

1.07

0.08

1.3

1.2

5.72

6.28

ug/l

—

Use of interferon beta-1a

1.05

0.08

1.2

1.5

3.33

5.90

ug/l

—

Postpartum haemorrhage

693

1.03

0.08

1.4

5.58

6.91

ug/l

0.57

615

Anisometropia and aniseikonia

0.79

0.08

1.2

1.5

4.56

8.15

ug/l

—

Benign neoplasm: Conjunctiva

0.78

0.08

1.0

1.3

6.10

6.24

ug/l

—

Premature rupture of membranes

504

0.96

0.08

1.4

1.3

6.72

5.90

ug/l

0.31

446

Ischaemic Stroke, excluding all haemorrhages

102

738

1.03

0.08

1.2

1.6

11.80

9.12

ug/l

0.31

666

Respiratory tuberculosis, confirmed and not-confirmed

0.77

0.08

3.0

1.4

8.12

8.16

ug/l

—

Respiratory tuberculosis

0.77

0.08

3.0

1.4

8.12

8.16

ug/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.09

0.08

1.1

1.6

5.14

7.92

ug/l

—

Congenital malformations of aortic and mitral valves

0.84

0.07

1.0

1.5

5.15

8.15

ug/l

—

Cholesteatoma of middle ear

0.82

0.07

1.0

1.6

6.03

11.02

ug/l

—

Urethral stricture

1.08

0.07

1.3

14.46

10.67

ug/l

—

Graves disease, strict definition

235

0.94

0.07

1.0

1.4

18.54

7.70

ug/l

0.37

202

Cirrhosis of liver, NAS

0.87

0.07

1.4

1.5

15.41

8.78

ug/l

—

Hypoplasia of dental enamel , including avohilmo

1.07

0.07

2.8

1.6

6.73

5.33

ug/l

—

Stroke, including SAH

119

882

0.98

0.07

1.2

1.6

11.22

9.07

ug/l

0.29

112

799

Benign neoplasm: Adrenal gland

138

1.09

0.06

1.1

1.6

5.34

8.79

ug/l

1.74

119

Alcohol-induced chronic pancreatitis

1.11

0.06

1.3

1.4

16.99

9.19

ug/l

0.61

L02BB Anti-androgens

103

0.87

0.06

1.0

1.5

4.71

9.88

ug/l

—

Other sexually transmitted chlamydial diseases

287

1.05

0.05

1.1

1.3

4.62

5.51

ug/l

0.79

252

Endovascular or surgical operations to intracerebral aneurysms

110

0.91

0.05

1.7

1.5

6.17

7.47

ug/l

—

Insulin medication

141

1168

1.02

0.04

1.2

1.6

11.96

7.87

ug/l

0.67

129

1066

Papillary adenocarcinoma of thyroid gland

1.10

0.04

1.8

1.5

7.76

7.11

ug/l

—

Aortic aneurysm

293

1.04

0.04

1.5

7.31

9.62

ug/l

0.91

267

Postpartum care and examination

296

1.03

0.03

1.5

1.3

6.21

5.50

ug/l

0.34

267

Stroke, excluding SAH

109

805

0.99

0.02

1.2

1.6

11.34

9.01

ug/l

0.28

102

725

Degeneration of macula and posterior pole

627

0.99

0.01

1.3

1.6

8.87

9.12

ug/l

0.06

572

Other retinal disorders

133

1029

1.01

0.01

1.3

1.5

12.41

8.68

ug/l

0.54

121

933

Delivery

118

618

1.01

0.01

1.6

1.5

6.85

7.82

ug/l

0.33

555

Colon adenocarcinoma

126

0.95

0.00

1.3

1.6

4.62

9.14

ug/l

2.93

110

Malignant neoplasm of thyroid gland

124

1.05

0.00

1.6

1.5

7.62

7.70

ug/l

0.02

103

Acute appendicitis, with complications

393

0.99

0.00

2.1

1.5

12.66

7.98

ug/l

0.32

346

Other and unspecified vascular occlusions

121

0.99

0.00

2.6

1.4

17.13

8.91

ug/l

1.30

104

Retinal vascular disorders

157

1.02

0.00

2.2

1.5

14.51

8.76

ug/l

1.08

138

Hyperplasia of prostate

310

1.01

0.00

1.5

1.6

16.09

8.18

ug/l

0.55

285

Diabetes mellitus in pregnancy

114

731

1.00

0.00

1.3

1.4

5.22

6.99

ug/l

1.35

104

652

Thyrotoxicosis with diffuse goitre

315

1.02

0.00

1.0

1.6

13.90

8.65

ug/l

0.27

278

Disorders of tooth development and eruption

315

1.00

0.00

1.4

1.6

6.18

7.35

ug/l

0.29

291

Retinal vascular occlusion

156

1.03

0.00

2.2

1.5

14.51

8.80

ug/l

1.07

137

Maternal care for known or suspected fetal abnormality and damage

426

0.99

0.00

1.3

1.4

10.54

7.09

ug/l

0.30

382

Polyhydramnios

128

1.02

0.00

1.2

1.3

6.05

6.22

ug/l

0.04

109

Combinations of oral blood glucose lowering drugs

509

1.00

0.00

2.0

1.7

12.17

9.84

ug/l

0.23

464

Malignant neoplasm of endocrine gland

133

0.98

0.00

1.6

1.5

7.62

8.04

ug/l

0.09

111

Physiological and behavioural disorders associated with sexual development and orientation

0.00

0.0

1.5

—

7.45

—

Disorders of olfactory nerve

0.00

0.0

1.3

—

8.30

—

Other secondary gout

0.00

0.0

1.3

—

7.40

—

Neuralgic amyotrophy

0.00

0.0

1.5

—

9.15

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.0

1.0

—

6.54

—

Chronic inflammatory disorders of orbit

0.00

0.0

1.1

—

6.44

—

Alopecia universalis

0.00

0.0

2.1

—

7.92

—

Erectile dysfunction, exclusion

0.00

0.0

1.0

—

5.33

—

Nondiabetic hypoglycaemic coma

0.00

0.0

1.7

—

8.90

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

0.0

1.0

—

5.66

—

Down's syndrome

0.00

0.0

2.0

—

6.93

—

Other congenital musculoskeletal deformities

0.00

0.0

1.8

—

6.70

—

Congenital malformations of lung

0.00

0.0

1.8

—

5.23

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

0.0

1.4

—

8.22

—

Pectus excavatum

0.00

0.0

1.1

—

6.16

—

Reduction defects of upper limb

0.00

0.0

1.3

—

7.29

—

Other inherited muscular atrophy

0.00

0.0

1.3

—

7.82

—

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

0.00

0.0

1.2

—

5.50

—

Enterobiasis

0.00

0.0

2.3

—

8.52

—

Rheumatoid lung disease

0.00

0.0

1.2

—

7.66

—

Diphtheria

0.00

0.0

3.0

—

7.52

—

Acute hepatitis B

0.00

0.0

1.6

—

7.75

—

Hereditary factor VIII deficiency

0.00

0.0

1.6

—

8.62

—

Malignant neoplasm of adrenal gland

0.00

-0.00

0.0

2.6

—

7.69

—

Crushing injury of head

0.00

-0.00

0.0

1.6

—

7.90

—

Unspecified multiple injuries

0.00

-0.00

0.0

1.4

—

7.65

—

Drowning to ice

0.00

-0.00

0.0

1.4

—

9.34

—

Neuroendocrine tumor and carcinoma of rectum

0.00

-0.00

0.0

1.5

—

7.82

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.4

—

7.58

—

Malignant neoplasm of thymus

0.00

-0.00

0.0

1.7

—

8.12

—

Myotonic dystrophy (Steinert)

0.00

-0.00

0.0

1.6

—

8.11

—

Mucinous and mucinous cystic tumor of rectum

0.00

-0.00

0.0

1.6

—

8.30

—

Exposure to controlled fire, not in building or structure

0.00

-0.00

0.0

1.4

—

8.66

—

Malignant neoplasm of renal pelvis

0.00

-0.00

0.0

1.6

—

9.18

—

Drug-induced myopathy

0.00

-0.00

0.0

1.0

—

6.02

—

Haemolytic-uraemic syndrome

0.00

-0.00

0.0

1.4

—

8.12

—

General- and plastic-surgery devices associated with adverse incidents

0.00

-0.00

0.0

1.3

—

6.97

—

Traumatic amputation of shoulder and upper arm

0.00

-0.00

0.0

1.0

—

5.62

—

Benign neoplasm: Lower jaw bone

0.00

-0.00

0.0

1.4

—

7.16

—

Discharge of firework

0.00

-0.00

0.0

1.0

—

5.65

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

-0.00

0.0

1.6

—

8.91

—

Benign neoplasm: Carotid body

0.00

-0.00

0.0

1.0

—

6.73

—

Deaf mutism, not elsewhere classified

0.00

-0.00

0.0

1.2

—

7.24

—

Malignant neoplasm of base of tongue

0.00

-0.00

0.0

1.1

—

4.99

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

-0.00

0.0

1.5

—

7.31

—

Injury of blood vessels at neck level

0.00

-0.00

0.0

1.1

—

6.81

—

Traumatic cerebral oedema

0.00

-0.00

0.0

1.0

—

5.77

—

Traumatic amputation of lower leg

0.00

-0.00

0.0

1.0

—

5.90

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.00

-0.00

0.0

1.6

—

8.18

—

Otorrhoea

0.00

-0.00

0.0

1.4

—

8.54

—

ILD medications: nintedanib

0.00

-0.00

0.0

1.3

—

6.80

—

Malignant neoplasm of brain

0.98

-0.00

1.0

1.6

4.42

10.84

ug/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

0.93

-0.00

1.2

1.7

5.73

8.26

ug/l

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.4

—

7.24

—

Unspecified transport accident

0.00

-0.00

0.0

1.3

—

7.82

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

-0.00

0.0

1.3

—

6.59

—

0.00

-0.00

0.0

1.3

—

7.52

—

Hip and thigh

0.00

-0.00

0.0

1.4

—

8.28

—

Other ill-defined and unspecified causes of mortality

0.90

-0.00

1.3

1.5

6.16

10.93

ug/l

—

Unicornuate uterus

0.00

-0.00

0.0

2.0

—

9.98

—

Other and unspecified water transport accidents

0.00

-0.00

0.0

1.4

—

7.76

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

2.2

—

7.03

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

-0.00

0.0

1.2

—

7.41

—

Wilms' tumor, including Hilmo

0.00

-0.00

0.0

2.0

—

6.86

—

Other congenital malformations of integument

0.00

-0.00

0.0

1.5

—

8.63

—

Reduction defects of upper limb

0.00

-0.00

0.0

1.5

—

8.14

—

Diphtheria

0.00

-0.00

0.0

3.0

—

7.52

—

Abnormal findings in peritoneal fluid saliva

0.00

-0.00

0.0

1.3

—

7.13

—

Schistosomiasis [bilharziasis]

0.00

-0.00

0.0

1.0

—

5.08

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.94

-0.00

1.0

1.3

3.92

5.79

ug/l

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

2.2

—

8.28

—

Tympanosclerosis

0.00

-0.00

0.0

1.0

—

5.94

—

Cytomegaloviral hepatitis

0.00

-0.00

0.0

1.3

—

7.90

—

Congenital ptosis

0.00

-0.00

0.0

2.2

—

6.66

—

Other and unspecified syphilis

0.00

-0.00

0.0

1.3

—

7.94

—

Other acquired deformities of musculoskeletal system and connective tissue

1.01

-0.00

1.6

1.4

7.58

6.52

ug/l

—

Aortic stenosis

0.00

-0.00

0.0

1.9

—

5.81

—

Congenital malformations of lung

0.00

-0.00

0.0

1.9

—

5.64

—

Other cestode infections

0.00

-0.00

0.0

1.3

—

8.62

—

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

-0.00

0.0

1.0

—

5.57

—

Other and unspecified postprocedural disorders of eye and adnexa

0.00

-0.00

0.0

1.0

—

5.86

—

Benign neoplasm: Thymus

0.00

-0.00

0.0

1.5

—

8.53

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.0

—

6.47

—

Psoas tendinitis

0.00

-0.00

0.0

1.5

—

9.20

—

Benign neoplasm: Respiratory system, unspecified

0.00

-0.00

0.0

1.7

—

10.13

—

Aortic stenosis

0.00

-0.00

0.0

2.0

—

5.53

—

Congenital hydrocephalus

0.00

-0.00

0.0

1.4

—

8.70

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.0

—

5.52

—

Fetal death of unspecified cause

0.00

-0.00

0.0

2.0

—

9.84

—

Chromomycosis and phaeomycotic abscess

0.00

-0.00

0.0

1.0

—

5.76

—

Other and unspecified syphilis

0.00

-0.00

0.0

1.2

—

7.90

—

Felty syndrome

0.00

-0.00

0.0

1.3

—

7.22

—

Malignant neoplasm of brain, including Hilmo

0.92

-0.00

1.0

1.8

7.93

10.40

ug/l

—

Drug-induced thyroiditis

0.00

-0.00

0.0

1.0

—

6.12

—

Osteomyelitis of vertebra

0.00

-0.00

0.0

1.3

—

7.72

—

Drug-induced dystonia

0.00

-0.00

0.0

1.3

—

7.44

—

Unspecified protein-energy malnutrition

0.00

-0.00

0.0

1.6

—

9.01

—

Non-small cell lung cancer, adenocarcinoma

0.88

-0.00

1.0

1.5

5.55

9.27

ug/l

—

Small plaque parapsoriasis

0.00

-0.00

0.0

1.0

—

4.86

—

Amblyopia ex anopsia

0.99

-0.00

1.5

1.4

6.71

6.13

ug/l

—

Pneumonia due to Streptococcus pneumoniae

0.99

-0.00

1.0

1.5

58.94

11.84

ug/l

—

Hypertensive encephalopathy

0.00

-0.00

0.0

1.3

—

7.09

—

Cyst of iris, ciliary body and anterior chamber

0.00

-0.00

0.0

1.4

—

7.18

—

Type 1 diabetes, strict definition, subgroup 2

0.00

-0.00

0.0

2.5

—

7.78

—

Lesion of medial popliteal nerve

0.00

-0.00

0.0

1.5

—

8.34

—

ILD medications: acetylcysteine

0.00

-0.00

0.0

1.3

—

6.84

—

Chylothorax

0.00

-0.00

0.0

1.0

—

6.81

—

Disorder of visual pathways, unspecified

0.00

-0.00

0.0

2.0

—

5.79

—

Benign neoplasm: Retina

0.00

-0.00

0.0

1.4

—

7.21

—

Mental and behavioural disorders due to hallucinogens

0.00

-0.00

0.0

1.6

—

9.16

—

Other dermatomyositis

0.00

-0.00

0.0

1.5

—

8.77

—

Pectus excavatum

0.00

-0.00

0.0

1.0

—

5.36

—

Open wounds involving multiple body regions

0.00

-0.00

0.0

1.0

—

5.48

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tryptase [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS